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CHAPTER 1
INTRODUCTION

Parts of this chapter have been submitted for publication to the journal BioMed
Research International.

Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, is
crucial for mitochondrial function and is involved in various cellular processes outside
of the mitochondria. The importance of CL in cardiovascular health is underscored by
the life-threatening genetic disorder Barth syndrome (BTHS), which manifests clinically
as cardiomyopathy, skeletal myopathy, neutropenia, and growth retardation. In
addition to BTHS, CL is linked to various cardiovascular diseases (CVDs), including
cardiomyopathy, atherosclerosis, myocardial ischemia-reperfusion injury, heart failure
and Tangier disease. The link between CL and CVDs may possibly be explained by
the physiological roles of CL in pathways that have cardioprotective function, such as
autophagy/mitophagy and the mitogen-activated protein kinase (MAPK) pathways. My
dissertation work focuses on elucidating how CL influences mitophagy and MAPK
pathways. This knowledge may contribute to our understanding of the function of this
important lipid, and may ultimately identify novel therapeutic strategies to treat CVDs
and improve heart performance.

1. CL and CL synthesis
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CL contains two phosphatidyl moieties joined by a central glycerol backbone,
forming a dimeric structure (De Bruijn, 1966). Thus, unlike other phospholipids that
contain two fatty acyl chains linked to glycerol, CL has four acyl chains. Considering
the potential combinations of fatty acyl groups on CL, a large number of CL species
may be possible. However, in most organisms and tissues, the fatty acyl composition
of CL is unique and specific. For example, bacterial CL contains both saturated and
monounsaturated fatty acyl chains that are composed of 14–19 carbons (Kito et al.,
1972). In eukaryotes, CL mainly contains monounsaturated and diunsaturated fatty
acyl chains that consist of 16–18 carbons (Schlame et al., 1993). In mammals, CL acyl
species vary in different tissues, but the most abundant species in the heart is
tetralinoleoyl CL. In yeast, the predominant fatty acyl species of CL are oleic acid and
palmitoleic acid (Schlame et al., 1993). While CL plays critical roles in mitochondrial
biogenesis, fusion and fission, respiration and protein import (Joshi et al., 2009), it is
also involved in various cellular processes outside of the mitochondria. These include,
but are not limited to cell wall biogenesis (Zhong et al., 2005), vacuole homeostasis
(Chen et al., 2008b), ageing (Zhou et al., 2009), the cell cycle (Chen et al., 2010), and
apoptosis (Li et al., 2015).
Unlike mitochondrial membrane lipids that are synthesized in the endoplasmic
reticulum, de novo synthesis of CL occurs exclusively in the inner membrane of the
mitochondria (Hostetler et al., 1972) in a series of well-characterized steps that are
conserved from yeast to higher eukaryotes (Tian et al., 2012). The first step in the CL
biosynthetic pathway is the conversion of phosphatidic acid (PA) to CDP-diacylglycerol
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(CDP-DAG), which is catalyzed in the inner membrane by CDP-DAG synthase
encoded by TAM41 (Deprez et al., 2002; Kutik et al., 2008; Tamura et al., 2013). The
PGS1-encoded phosphatidylglycerolphosphate (PGP) synthase catalyzes transfer of
the phosphatidyl group from CDP-DAG to a glycerol-3-phosphate molecule to generate
PGP

(Chang

et

al.,

1998b).

PGP

is

subsequently

dephosphorylated

to

phosphotidylglycerol (PG) by PGP phosphatase, encoded by PTPMT1 in mammals
(Xiao et al., 2011; Zhang et al., 2011) and GEP4 in yeast (Osman et al., 2010).

The

final step in the biosynthetic pathway is carried out by CL synthase, encoded by hCLS1
in human cells (Chen et al., 2006; Houtkooper et al., 2006; Lu et al., 2006) and by
CRD1 in yeast (Chang et al., 1998a; Jiang et al., 1997; Tuller et al., 1998). In this step,
a second phosphatidyl group is added to PG from another CDP-DAG molecule,
generating CL (Hostetler et al., 1972; Houtkooper et al., 2006; Malhotra et al., 2009).
The acyl composition of CL varies in different tissues, and the CL remodeling
process is responsible for the CL acyl group exchange following CL de novo synthesis.
CL remodeling may occur through two mechanisms (Ye et al., 2014b). In the two-step
mechanism, CL is first deacylated to monolyso-CL (MLCL) by phospholipases (Lands,
1960). In yeast, the only CL-specific phospholipase is encoded by CLD1 (Beranek et
al., 2009), while in mammals, several phospholipases are reported to have CLhydrolyzing activities, including iPLA2β, iPLA2γ, cPLA2, and sPLA2 (Buckland et al.,
1998; Dennis et al., 2011; Hsu et al., 2013). MLCL is reacylated to remodeled CL by
the transacylase tafazzin, encoded by the tafazzin gene (TAZ/G4.5) located on Xq28
in human cells (Bione et al., 1996) and by TAZ1 in yeast (Gu et al., 2004; Vaz et al.,
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2003). Acyltransferases encoded by ALCAT1 (Cao et al., 2004) and MLCLAT1 (Taylor
and Hatch, 2009) have also been described in mammalian cells. In the one-step
mechanism, CL remodeling occurs by direct transacylation (Xu et al., 2003; Yamashita
et al., 1997). Mutations in tafazzin perturb CL remodeling and cause the lifethreatening genetic disorder Barth syndrome (BTHS) (Barth PG et al., 1983), which is
discussed below.
The CL synthesis and remodeling pathway in my research model,
Saccharomyces cerevisiae, is shown in Fig. 1.1.

2. Relationship between CL and CVD
2.1 CL and cardiomyopathy
2.1.1 Barth syndrome
The most direct link between CVD and CL is seen in BTHS, an X-linked genetic
disorder of CL remodeling caused by tafazzin mutations. BTHS manifests clinically as
cardiomyopathy, skeletal myopathy, neutropenia, and growth retardation (Barth et al.,
1999). More than 160 mutations in the tafazzin gene have been identified in BTHS
patients (Chen et al., 2002; D'Adamo et al., 1997; Hijikata et al., 2015). These
mutations result in loss of function of tafazzin, leading to decreased cellular CL,
increased MLCL, and altered CL fatty acyl composition (Schlame et al., 2003; Schlame
et al., 2002; Valianpour et al., 2002). Total CL is decreased to about 80% in BTHS
platelets and skeletal muscle and 20% in cardiac tissue (Schlame et al., 2002). CL
species vary in different tissues. Tetralinoleoyl-CL (L4-CL) is the most abundant

5

Fig. 1.1 Cardiolipin synthesis and remodeling pathway in Saccharomyces
cerevisiae. Cited from Ye et al. 2014b. Cited from Ye et al. 2014b. The first
reaction of CL de novo synthesis is the conversion of phosphatidic acid (PA) to
CDP-diacylglycerol (CDP-DAG) by the mitochondrial CDP-DAG synthase
Tam41. The committed step of CL synthesis is catalyzed by Pgs1, which
converts CDP-DAG to phosphatidylglycerolphosphate (PGP). PGP is
subsequently dephosphorylated to phosphatidylglycerol (PG) by the GEP4encoded PGP phosphatase. CL synthase, encoded by CRD1, condenses PG
and CDP-DAG to form CL. CL synthesized de novo has primarily saturated acyl
chains (CLSAT). CLSAT is deacylated by the CL-specific phospholipase Cld1 to
monolysocardiolipin (MLCL), which is reacylated by tafazzin (the TAZ1 gene
product) to CL containing more unsaturated acyl chains (CLUNSAT). All the CL
biosynthetic enzymes are localized in the mitochondrial inner membrane (IM),
whereas tafazzin is localized in the outer face of the (IM) and the inner face of
the outer membrane (OM). IMS: intermembrane space.
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CL species in heart, skeletal muscle and most other tissues, whereas acyl species
such as arachidonic and docosahexaenoic acids are found in brain (Cheng et al., 2008;
Houtkooper and Vaz, 2008; Schlame and Ren, 2006). L4-CL is absent in BTHS,
while increases in other CL species are present (Schlame et al., 2003; Schlame et al.,
2002; Valianpour et al., 2002).
Understanding the cellular function and molecular mechanisms of CL remodeling
may provide better treatment options for BTHS patients (Ye et al., 2014b). Tafazzin
deficiency results in decreased CL, increased MLCL, and altered CL species, any of
which may cause the pathology in BTHS. Recent findings in yeast indicate that deletion
of Cld1p-mediated deacylation rescues growth and lifespan defects in tafazzin
deficient cells (Baile et al., 2013; Ye et al., 2014a). Because the cld1 mutation restored
CL levels without generating remodeled CL, these findings suggest that decreased
total CL and/or increased MLCL, but not decreased remodeled CL, causes the defects
associated with tafazzin deficiency. Inhibiting CL deacylation may, thus, be a potential
strategy to treat BTHS patients.

2.1.2 Dilated cardiomyopathy with ataxia (DCMA) syndrome
DCMA syndrome is an autosomal recessive genetic disorder that is
characterized by early onset dilated cardiomyopathy with conduction defects, nonprogressive cerebellar ataxia, testicular dysgenesis, growth failure, and 3methylglutaconic aciduria (Davey et al., 2006). These clinical manifestations are similar
to phenotypes found in BTHS. Patients with DCMA have a common mutation, a GC
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base substitution within a splice site of the DNAJC19 gene (Davey et al., 2006).
DNAJC19 protein localizes to the mitochondria and shares sequence and location
similarity with yeast Tim14, an essential subunit of the TIM23 complex (D'Silva et al.,
2003; Mokranjac et al., 2003). TIM23 is required for the import of protein precursors
from the cytoplasm into the mitochondrial matrix and inner membrane (Rehling et al.,
2003). This suggests that the DCMA phenotype may result from defective
mitochondrial protein import. Interestingly, loss of CL also leads to defective
mitochondrial protein import (Eilers et al., 1989; Endo et al., 1989; Endo and Schatz,
1988; Gebert et al., 2009; Jiang et al., 2000). Therefore, it is interesting to speculate
that defective mitochondrial protein import may be common to DCMA and BTHS. A
recent study suggests that CL may play a role in the pathogenesis of DCMA (RichterDennerlein et al., 2014). DNAJC19 protein is reported to form the PHB/DNAJC19
complex with prohibitin, a ring-like scaffold protein located in the mitochondrial inner
membrane. The PHB/DNAJC19 complex modulates CL remodeling by regulating
tafazzin activity. Depletion of DNAJC19 does not affect CL or MLCL levels but alters
the acyl chain composition of CL (Richter-Dennerlein et al., 2014). However, if the
cause of DCMA is due to defective protein import, altered CL fatty acyl species, or a
combination of the two remains unknown.

2.1.3 Diabetic cardiomyopathy
Diabetes is a metabolic disease characterized by increased levels of glucose in
the blood over a prolonged period. It is due to either poor insulin production (type I) or
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insulin resistance with β-cell dysfunction (type II) (He and Han, 2014).
Diabetic complications are characterized by a group of diseases derived from
microvascular and macrovascular damage, including diabetic cardiomyopathy,
myonecrosis,

stroke,

peripheral

vascular

disease,

nephropathy, retinopathy

and encephalopathy (Nathan, 1993). Diabetes doubles the risk of CVD, of which
diabetic cardiomyopathy is the leading cause of mortality. Diabetic cardiomyopathy is
characterized by altered lipid composition and mitochondrial dysfunction in the diabetic
myocardium (Han et al., 2000). In the early stages of pathological development in the
type II diabetic mouse model, a sharp decrease in total cardiac CL is observed (Han
et al., 2005). In addition to a decrease in the whole cell CL content, there is also a shift
from the predominant fatty acyl species, L4-CL (18:2) to longer and polyunsaturated
fatty acids, due to aberrant CL remodeling (Han et al., 2007). Strikingly, these
alterations are similar to changes observed in the type I model of diabetes. In type II
diabetic mice, treatment with the antidiabetic drug rosiglitazone restored total CL, L4CL, and polyunsaturated CL levels (Pan et al., 2006). Impairment of CL synthesis plays
a causal role in mitochondrial dysfunction (Koshkin and Greenberg, 2002;
Mileykovskaya and Dowhan, 2014a; Pfeiffer et al., 2003), and mitochondrial
dysfunction is associated with the pathogenesis of diabetic CVD, especially the
sequential events following silent myocardial ischemia in diabetics (Sack, 2009). Thus,
the sharp decrease in total cardiac CL and the altered CL fatty acyl species in the early
stages of diabetic pathogenesis may play a key role in the progression of this disease.

9

2.2 CL is associated with other CVDs
In addition to its role in cardiomyopathy, CL has been linked to other CVDs,
including atherosclerosis, Tangier disease, myocardial ischemia-reperfusion and heart
failure.
Atherosclerosis is a form of arteriosclerosis in which an artery wall thickens due
to chronic invasion and further accumulation of white blood cells (WBC), remnants of
dead cells, cholesterol, and triglycerides (Ross, 1993). Oxidized CL (oxCL) was found
to accumulate both in rabbit and human atherosclerotic lesions (Tuominen et al., 2006),
and in the aortic root of mice fed a high fat diet (Zhong et al., 2014). Increased antioxCL IgG (Lopez et al., 2003; Marai et al., 2008; Türkoğlu et al., 2008) and IgM (Su et
al., 2013; Türkoğlu et al., 2008) antibodies are associated with atherosclerosis
development. oxCL is recognized as a natural antigen that stimulates pro-inflammatory
effects in the artery and promotes formation of atherosclerotic plaques (Bochkov et al.,
2010; Marai et al., 2008). However, some studies purport that autoantibodies to oxCL
may serve a protective role against the onset and development of atherosclerosis
(Frostegård et al., 2014; Su et al., 2006). The seemingly contradictory findings
regarding the role of anti-oxCL antibodies in atherosclerosis may reflect the influence
of other factors, including age, gender and existing diseases. The anti-coagulation
protein annexin A5 has been reported to bind to and inhibit the pro-inflammatory effects
of oxCL (Wan et al., 2014), providing the basis of a promising therapeutic strategy for
oxCL-positive atherosclerosis.
Tangier disease (TD) is another genetic disorder that may be linked to CL. TD is
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a disorder of cholesterol efflux and lipid metabolism characterized by a nearly complete
absence of plasma high-density lipoproteins (HDLs), atherosclerosis, peripheral
neuropathy and an increased risk for developing CVD (Fredrickson, 1964; Oram,
2000). The genetic cause of TD is mutations of the ABCA1 gene, which is located on
chromosome 9 (Rust et al., 1999). ABCA1 encodes a highly conserved ATP binding
cassette transporter that belongs to a subfamily of ABC transporters. The ABCA
subfamily is involved in lipoprotein metabolism and lipid transport across the plasma
membrane (Knight, 2004). Researchers propose that a physical interaction between
apoA-I and ABCA1 results in the formation of a phospholipid-apoA-I complex that
promotes cholesterol efflux (Wang et al., 2001). Three phospholipids, including CL and
lysoCL 1 and 2 (LC1 and LC2), which together contribute only a small fraction of the
total cellular phospholipid content, were found to be enriched up to five-fold in TD
fibroblasts compared to wild type (WT) cells (Fobker et al., 2001). This finding suggests
that phospholipid and cholesterol efflux may be co-regulated and, therefore, dually
impaired in TD cells. Additionally, it is possible that increased CL may play an as yet
uncharacterized regulatory role in cholesterol trafficking and efflux.
In addition to the above disorders, the CL profile is altered in both myocardial
ischemia-reperfusion injury and heart failure. Myocardial ischemia occurs when the
myocardium does not receive sufficient blood flow, resulting in cell death and
further irreversible injury (Carden and Granger, 2000). Restoration of circulation in
ischemic myocardium exacerbates the injury (Carden and Granger, 2000). In the early
stages of myocardial ischemia, there is an increase in reactive oxygen species (ROS).
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During and post ischemia-reperfusion, ROS is thought to trigger lipid peroxidation as
well as damage to cellular macromolecules and the electron transport chain, which
together lead to apoptosis, necrosis and tissue damage (Ferrari et al., 1991; Kalogeris
et al., 2014; Kloner et al., 1989). Unsaturated CL acyl species in the mitochondrial inner
membrane that are close to the site of ROS generation are vulnerable to oxidative
damage. Consistent with this, total CL was decreased and peroxidized CL was
increased in the rat heart during ischemia-reperfusion (Paradies et al., 1999). A study
of ischemia-reperfusion in rabbit heart reported that reduction of total CL was due in
large part to a significant decrease in CL in the subsarcolemmal mitochondria, whereas
CL in the interfibrillar mitochondria was unchanged (Lesnefsky et al., 2001). The levels
of all other phospholipids remained unaffected in the same study. Decreased CL was
shown to have an impact on electron transport chain complexes I (Paradies et al.,
2004), III (Petrosillo et al., 2003), and IV (Paradies et al., 1999). The enzyme activies
of these complexes in mitochondria from the ischemic rat heart was restored by the
addition of exogenous CL, but not by other phospholipids or peroxidized CL (Paradies
et al., 1999). In summary, a feedback loop appears to be formed, in which CL is
damaged by ischemia-reperfusion-induced ROS, and damaged CL leads to
impairment of electron transport chain complexes, resulting in the generation of more
ROS. In addition, the fact that membranes containing peroxidized CL are more
permeable to apoptosis factors (Korytowski et al., 2011) may suggest a route through
which ROS triggers apoptosis and tissue damage.
Heart failure (HF) occurs when the heart is not able to contract efficiently enough
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to pump blood to meet the body’s needs. The major clinical symptoms of HF include
edema, shortness of breath and lack of energy. HF is usually the end stage of CVD,
including cardiomyopathy, heart attack, cardiac valvular disease, atrial fibrillation, and
high blood pressure (McMurray and Pfeffer).

In both the spontaneously hypertensive

HF rat (SHHF) and human HF patients, decreased tafazzin mRNA levels were
observed,

concomitant

with

compensatory

increases

in

the

activity

of

phosphatidylglycerolphosphate synthase and MLCL acyltransferase (Saini-Chohan et
al., 2009). However, studies of the CL profile in HF are controversial. While most
studies report a significant reduction of total CL and L4-CL in human HF (Chatfield et
al.; Le et al., 2014; Sparagna et al., 2007) and in the rat HF model (Reibel et al., 1986;
Sparagna et al., 2007), one study reported an unchanged CL profile in a rat model with
intracoronary microembolization-induced HF (Rosca et al., 2011). It is likely that
different HF pathogenesis mechanisms lead to varying degrees of CL profile change
and mitochondrial damage.

3 CL plays a role in cellular events and pathways that are important for
maintaining cardiovascular health
3.1 Autophagy/mitophagy
Autophagy refers to the cellular process in which cytoplasmic contents are
delivered to the lysosome or vacuole for degradation. Autophagy is further classified
into selective and nonselective autophagy (Nair and Klionsky, 2005). Various types of
selective autophagy have been identified, including mitophagy, pexophagy, lipophagy,
nucleophagy, lysophagy, reticulophagy/ER-phagy and ribophagy (Okamoto, 2014).
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Mitophagy is the selective degradation of mitochondria by autophagy (Wang and
Klionsky, 2011). Mitophagy and autophagy are generally not distinguished in studies
of CVD and will be discussed together here.
In the heart, autophagy is an important housekeeping process and is essential
for maintaining cardiac health (Moyzis et al., 2015). Autophagic activity declines with
age, and decreased or impaired autophagy leads to accumulation of proteins and
damaged mitochondria, contributing to cardiac aging (Linton et al.). In addition,
deletion of ATG5, the gene encoding a protein that regulates phagophore expansion,
is known to result in cardiomyopathy in mice (Nakai et al., 2007).
As discussed above, decreased CL causes impairment of the electron transport
chain complexes I (Paradies et al., 2004), III (Petrosillo et al., 2003) and IV (Paradies
et al., 1999), resulting in mitochondrial dysfunction. In response to mitochondrial
damage, mitophagy increases as an adaptive and protective strategy to eliminate
damaged mitochondria (Frank et al., 2012; Narendra et al., 2008). Therefore, I
undertook the study in this thesis to investigate if the loss of CL leads to altered
mitophagy.

3.2 CL and MAPK pathways
3.2.1 PKC pathway
Protein kinase C (PKC) is a family of protein kinases that regulate the function of
other proteins through

specific

phosphorylation of hydroxyl groups

on threonine

and serine residues. Human cells have fifteen PKC isozymes (Mellor and Parker,
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1998). Over-stimulation of PKCα, PKCβ, PKCδ or PKCε results in hypertrophy of
cardiomyocytes through activation of the extracellular signal-related kinase (ERK)
pathway (Steven P. Marso and Stern, 2003). However, during ischemia preconditioning,
PKCα, PKCδ, PKCε and PKCη have been shown to translocate to the active
membrane pool and perform cardioprotective functions (Steven P. Marso and Stern,
2003). Activation of PKCδ results in intracellular pH changes and viability protection;
activation of PKCη protects against myocardial stunning; activation of both PKCδ and
PKCη provides global myocardial protection against necrosis, acidosis, and
myocardial stunning (Meldrum et al.). Blocking the phosphatidylinositol-specific
phospholipase C (PI-PLC)-induced translocation of PKCα, PKCε, and PKCη during
ischemia impairs myocardial recovery (Munakata M et al., 2002). Therefore, PKC
isozymes have dual functions in the pathogenesis and progression of CVD. However,
unlike other PKC isozymes that affect different CVDs, PKCη is mainly reported to play
a cardioprotective role during ischemia.
Yeast has only one PKC (Pkc1p). Human PKCη is the only human PKC isozyme
that can complement the defects caused by deletion of PKC1 in yeast through
activation of the same protein kinase cascade (Nomoto S et al., 1997). This suggests
that PKCη shares both functional and structural homology with Pkc1p. A previous study
in yeast showed that loss of PG, the precursor of CL, leads to defects in the activation
of the PKC pathway (Zhong et al., 2007). Extrapolating from the finding in yeast that
the CL precursor is required for PKC pathway activation, the cardioprotective role of
PKCη activation during ischemia preconditioning may be dependent on CL. In yeast,
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PKC activation is also required for mitophagy (Mao et al., 2011), another
cardioprotective process. Thus, to investigate how CL plays a role in maintaining
cardiovascular health, it is necessary to determine if CL is required for PKC pathway
activation.

3.2.2

HOG pathway
The high osmolarity glycerol (HOG) pathway is a highly conserved MAPK

pathway that mediates the cellular response to hyperosmotic shock. In yeast, the HOG
pathway consists of two stress-sensing branches, SLN1 and SHO1 branches (Saito
and Tatebayashi, 2004). Both branches are cascades that lead to phosphorylation of
Hog1p, the yeast homolog of the mammalian MAPK p38, which functions in
the inflammatory and stress responses (Raingeaud et al., 1995). Phosphorylation
activates Hog1p and promotes translocation into the nucleus. The phosphorylated
protein (pHog1p) induces transcription of GPD1, and GPP2, which encode glycerol-3phosphate dehydrogenase and glycerol-3-phosphate phosphatase, respectively (Rep
et al., 2000). These enzymes are involved in the production of glycerol, the cytosolic
accumulation of which counteracts osmotic stress. Activated Hog1p also regulates
intracellular ion homeostasis by phosphorylating the C-termini of Nha1p, the Na+/H+
antiporter on the plasma membrane, and Tok1p, the potassium channel on the plasma
membrane (Proft and Struhl, 2004). In addition to regulating glycerol biogenesis and
ion homeostasis, pHog1p regulates the transcription of about 600 genes, resulting in
cellular adaptation to various stresses (O'Rourke and Herskowitz, 2004).
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A previous study showed that CL mutants exhibit vacuole defects that are
characterized by enlarged vacuoles and loss of vacuole acidification (Chen et al.,
2008b). The vacuole defects were rescued by deletion of NHX1, which encodes the
Na+/H+ and K+/H+ exchanger, suggesting that ion homeostasis is perturbed in CL
mutants. The vacuole defects were also rescued by supplementation with 1 M sorbitol,
a HOG pathway stimulant, suggesting that osmoregulation may be perturbed in CL
mutants. Because the HOG pathway functions in both osmoregulation and intracellular
ion homeostasis, it is necessary to determine if the HOG pathway is perturbed in CL
mutants.

4

Saccharomyces cerevisiae as my research model
As discussed above, CL biosynthesis is highly conserved from yeast to humans.

The yeast taz1Δ mutant exhibits respiratory and metabolic deficiencies similar to those
in human BTHS cells (Chen et al., 2008a; Gu et al., 2004; Ma et al., 2004). In addition,
the availability of null mutants for each step of CL synthesis facilitates studies to
elucidate CL function, which are not easily carried out in higher eukaryotes. For
example, the finding that growth and respiratory defects of the yeast taz1 mutant are
rescued by deletion of CLD1, which restores CL/MLCL levels without generating
remodeled CL, suggests that CL/MLCL levels are more important for mitochondrial
function than CL acyl composition (Baile et al., 2014; Ye et al., 2014a). This study could
not be carried out in mammalian cells, as CL phospholipases have not been
characterized in mammals.
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Most of the studies described in this thesis utilize the crd1Δ null mutant, in which
the gene for CL synthase is deleted. The crd1Δ mutant has no CL and accumulates
the CL precursor, PG. I also utilized the yeast genome deletion collection, which
facilitated me to carry out genetic interaction studies. The genetic and molecular tools
of the yeast model enabled me to carry out my analysis of the role of CL in mitophagy
and the MAPK pathways.

5

Project outline
The goal of my doctoral research was to investigate the role of CL in cellular

events and pathways that are required for maintaining cardiovascular health. I
specifically focused on the role of CL in mitophagy, and the mechanism underlying this
connection.
The study described in Chapter 2 shows that the loss of CL leads to defective
mitophagy. Synthetic lethality with autophagy/mitophagy mutants suggested that
mitophagy may be deficient in crd1Δ. Microscopic examination of mitophagy revealed
decreased translocation of GFP-tagged mitochondrial protein into the vacuole of crd1Δ
cells. This was confirmed by immunoblotting detection of free GFP, which was
generated by cleavage of GFP-tagged mitochondrial protein after it was delivered into
the vacuole by mitophagy. These findings indicated that mitophagy is decreased in CL
deficient cells.
Chapter 3 describes a possible mechanism underlying defective mitophagy in
crd1Δ. It is known that the PKC pathway is required for early stages of mitophagy and
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the HOG pathway is required for later stages (Mao et al., 2011). My studies showed
that crd1Δ growth defects are exacerbated by downregulation of the HOG pathway
and rescued by upregulating the PKC pathway, suggesting that these MAPK pathways
may be defective in CL mutants. Consistent with this, Western blot experiments
showed decreased phosphorylation of Slt2p and Hog1p in crd1Δ, indicating defective
activation of the PKC and HOG pathways. Interestingly, upregulation of PKC rescued
defective mitophagy in crd1Δ. These results suggest that the mechanism underlying
defective mitophagy in crd1Δ cells is defective MAPK function.
Although the findings of my dissertation research shed light on the role of CL in
pathways known to be important for maintaining cardiovascular health, the story is far
from over. Chapter 4 describes exciting experiments that can be done to elucidate the
mechanism underlying the role of CL in mitophagy and the MAPK pathways. In addition,
follow up experiments are proposed to continue preliminary studies of the role of CL in
vacuole homeostasis.
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CHAPTER 2
LOSS OF CARDIOLIPIN LEADS TO DEFECTIVE MITOPHAGY
Introduction
Cardiolipin (CL) is the signature lipid of mitochondrial membranes. It plays an
important role in mitochondrial function through interacting with various mitochondrial
membrane proteins, including electron transport chain (ETC) complex proteins that
are components of complex I (Fry and Green, 1981; Mileykovskaya and Dowhan,
2014b), complex III (Fry and Green, 1981; Pfeiffer et al., 2003; Zhang et al., 2002;
Zhang et al., 2005), complex IV (Pfeiffer et al., 2003; Zhang et al., 2002; Zhang et al.,
2005), complex V (Gohil et al., 2004), cytochrome c (Ranieri et al., 2015) and
transporter proteins such as the ADP-ATP carrier (Beyer K and M., 1985), pyruvate
carrier (Paradies and Ruggiero, 1988) and phosphate carrier (Kadenbach et al., 1982).
Loss of CL leads to impaired mitochondrial function, including defective respiration
(Schlame and Ren, 2006), decreased mitochondrial membrane potential (Jiang et al.,
2000) and impaired mitochondrial protein import (Gebert et al., 2009; Jiang et al.,
2000). Additional cellular functions of CL outside of mitochondria are continuously
being explored.
In studies described in this chapter, I investigated the role of CL in mitophagy.
Mitophagy is the selective degradation of mitochondria through autophagy (Wang and
Klionsky, 2011). Autophagy is the cellular process in which cytoplasmic contents are
delivered into the lysosome or vacuole for degradation. According to the different ways
by which cargos are delivered to the lysosome/vacuole for degradation, autophagy is
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classified as macroautophagy, microautophagy, and chaperone-mediated autophagy
(Shintani and Klionsky, 2004). Autophagy is further classified as selective or
nonselective, depending on whether specific cargo is selected (Nair and Klionsky,
2005). Various types of selective autophagy have been identified (Okamoto, 2014),
among which mitophagy is the selective degradation of mitochondria (Wang and
Klionsky, 2011). In the heart, autophagy is essential for maintaining cardiac health
(Moyzis et al., 2015). Impairment of the process by deletion of ATG5 has been
demonstrated to cause cardiomyopathy in mice (Nakai et al., 2007), linking abnormal
autophagy to cardiomyopathy.
Cardiomyocytes have a remarkably high mitochondrial density that comprises
about 30% of the total intracellular volume (Maack and O’Rourke, 2007). This allows
cardiomyocytes to produce ATP quickly to satisfy the high demand for energy. Even
subtle alterations in mitochondrial function or membrane potential can cause a
significant change in cardiomyocyte energy production and further harm
cardiovascular health. In response to mitochondrial damage, mitophagy increases as
an adaptive and protective strategy (Frank et al., 2012; Narendra et al., 2008).
Therefore, I carried out studies to determine if loss of CL, which perturbs numerous
mitochondrial functions, leads to altered mitophagy.
Genetic interaction analysis is a very powerful approach to study gene function.
Rescue of a mutant phenotype by deletion of another gene identifies suppression of
the mutant phenotype. Exacerbation of a mutant phenotype to lethality by deletion of
another gene is defined as synthetic lethality, which suggests that the two genes may
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work in redundant pathways. I predicted that genetic interaction analysis between
autophagy/mitophagy genes and CRD1 would shed light on the role of CL in mitophagy.
Although mitophagy occurs via both macro- and micro-autophagy (Kanki et al.,
2009c; Kiššová et al., 2007; Nowikovsky et al., 2007; Okamoto et al., 2009),
degradation of mitochondria via macro-autophagy is the dominant process when
mitophagy is triggered by nitrogen starvation or glucose deprivation (Kiššová et al.,
2007). During macro-mitophagy, mitochondria are recognized as the cargo that is
brought to the phagophore assembly site (PAS), where the double-membrane of the
phagophore expands and closes to form a mature mitophagosome that contains
mitochondria. Macro-mitophagy adapts the general autophagy core machinery, which
involves various autophagy-related (ATG) proteins, including the Atg1p/Atg13p
complex, Atg9p, Atg18p-Atg2p complex, Atg8p conjugation system (Atg3p, Atg4p,
Atg7p, and Atg8p), and the Atg12 ubiquitin-like conjugation system (Atg5p, Atg7p,
Atg10p, Atg12p, and Atg16p) (Köfinger et al., 2015; Reggiori et al., 2005; Reggiori et
al., 2004; Sakoh-Nakatogawa et al., 2015; Suzuki et al., 2001; Suzuki et al., 2007; Xie
and Klionsky, 2007). Atg8p is the yeast homolog of mammalian LC3, and it is
conjugated to phosphatidylethanolamine (PE) (Kirisako et al., 1999). Atg8p-PE coats
the mitophagosome membrane during membrane elongation. Phosphatidylinositol 3phosphate (PI3P) is another important lipid that constitutes the mitophagosome
membrane (Gillooly et al., 2000). Atg18p binds to PI3P and regulates the retrieval of
Atg9p from PAS, and normal transport of Atg9p between PAS and the peripheral site
is essential in PI3P synthesis on the mitophagosome membrane (Reggiori et al.,
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2005). Thus, Atg8p and Atg18p are essential proteins in the general autophagy core
machinery.
The mitochondrial outer membrane protein Atg32p plays a key role in selecting
mitochondria as the specific cargo. When mitophagy is triggered, Atg32p is
phosphorylated (Aoki et al., 2011). Then it interacts with Atg11p, which directs
mitochondria to the PAS, where an Atg32–Atg11–Atg8 initiator complex is formed
(Aoki et al., 2011; Farré et al., 2013). When an intact mitophagosome is formed and
delivered to the vacuole, the mitophagosome outer membrane fuses with the vacuole
membrane and releases the mitochondria wrapped by the mitophagosome inner
membrane into the vacuole lumen for degradation.
In this chapter, I investigated if loss of CL in the crd1Δ mutant leads to altered
mitophagy. Deletion of autophagy/mitophagy genes exacerbated the crd1Δ growth
defect. Mito-GFP marker tracking experiments and Western detection of free GFP, the
mitophagy product, both showed inhibited mitophagy in crd1Δ compared to WT. These
findings suggest that CL plays a novel role in mitophagy.
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Methods and materials
Yeast strains and growth media
The Saccharomyces cerevisiae strains used in this work are listed in Table 2.1.
Yeast extract peptone dextrose (YPD) medium contained yeast extract (1%), peptone
(2%), and glucose (2%). Synthetic complete (SC) medium contained lab-made
vitamin-free yeast nitrogen base without amino acids (Difco protocol, 0.17% ),
ammonium sulfate (0.5%), glucose (2%), vitamins, and the following amino acids:
adenine (20.25 mg/liter), arginine (20 mg/liter), histidine (20 mg/liter), leucine (60
mg/liter), lysine (200 mg/liter), methionine (20 mg/liter), threonine (300 mg/liter),
tryptophan(20 mg/liter), and uracil (20 mg/liter). Synthetic drop-out medium contained
all ingredients mentioned above except the amino acid used as the selective marker.
Synthetic lactate (SL) medium contained lab-made vitamin free yeast nitrogen base
without amino acids (Difco protocol, 0.17%), ammonium sulfate (0.5%), and lactate
(2%). Solid medium contained agar (2%).

Construction of deletion mutants and strains that express GFP-tagged
mitochondrial proteins
Deletion mutants were constructed as follows. The entire open reading frame of
the target gene was replaced by a KanMX4 cassette via homologous recombination
in the wild type (WT) strain. The KanMX4 cassette was amplified by polymerase chain
reaction (PCR), using the pUG6 plasmid, which contains the KanMX4 cassette, as the
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template. The amplification primers consisted of 50 nucleotides that were identical to
either the upstream or the downstream flanking region of the target gene at the 5’ end
and 21 nucleotides that annealed to the KanMX4 gene at the 3’ end. For construction
of the single mutants with the target mitophagy gene deleted, the PCR product was
transformed into the WT strain by electroporation. For construction of the double
mutants with both CRD1 and the target mitophagy gene deleted, the PCR product
was transformed into the crd1Δ strain by electroporation. Transformants were
selected on YPD plates with 200 μg/ml G418. Deletion of the target gene was
confirmed by PCR using primers that amplify the original target gene.
To monitor mitophagy in both WT and crd1Δ strains, the mitochondrial matrix
protein Idh1p in both strains was tagged by GFP as previously described (Kanki et al.,
2009a). The pFA6a-GFP (S65T)-HIS3MX6 plasmid (kindly provided by Dr. Daniel
Klionsky, University of Michigan) was used as the PCR template to amplify a DNA
fragment that encodes GFP with HIS3 as the selective marker. The primers consisted
of 50 nucleotides that were identical to either the upstream or the downstream flanking
region of the IDH1 ending code (TAA) at the 5’ end and 20 nucleotides that annealed
to the GFP sequence on the plasmid at the 3’ end. The sequences of these primers
are 5’-CTTCTACTACTGACTTCACGAATGAAATCATCAACAAATTATCTAC
CATGCGGATCCCCGGGTTAATTAA-3’ and 5’-AATTTGAACACACTTAAGTTGCAG
AACAAAAAAAAGGGGAATTGTTTTCAGAATTCGAGCTCGTTTAAAC-3’. The PCR
product was then transformed into both WT and crd1Δ cells in the BY4742 and FGY
genetic backgrounds by electroporation, and inserted into the end of the IDH1 locus
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via homologous recombination. The transformants that express IDH1-GFP were
selected on SC his- medium. Correct GFP insertion was confirmed by PCR analysis,
using

confirmation

primers

5’-ATGCTGTCTTCGAACCAGGTT-3’

and

5’-

AGTTCATCCATGCCATGTGT-3’.
Another approach to construct strains containing GFP-tagged mitochondria was
to transform the pCu416-IDP1-GFP plasmid that expresses IDP1-GFP (kindly
provided by Dr. Hagai Abeliovich, Hebrew University) into WT and crd1Δ, by
electroporation. Transformants carrying the plasmid encoding IDP1-GFP were
selected on SC ura- medium.

Single colony formation analysis
Cells were pre-cultured in YPD at 30˚C to the mid-log phase. The absorbance at
550 nm (A550) of the liquid culture was determined using a spectrophotometer
(Beckman). Cell aliquots were centrifuged and pellets were resuspended in YPD to
adjust the A550 value to 10 units per ml. 10 μl of the above sample were added to 990
μl of water. 10 μl of the 100X diluted sample were placed on a hemocytometer for cell
counting using light microscopy at a magnification of 1000 X. Based on cell number,
cell aliquots with A550 of 10 were adjusted again and serial diluted to 2000 cells/ml,
from which 100 μl suspension that contained about 200 cells were plated on a YPD
plate and incubated at 30˚C, 36˚C or 37˚C for 3 days. The ability of single cells to form
colonies was evaluated at 30˚C, 36˚C or 37˚C.
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Table 2.1 Yeast strains and plasmids used in Chapter 2
Strain/plasmid

Characteristics or genotype

Source or reference

FGY3 (WT)

MAT α, ura3‐52, lys2‐801, ade2‐101, trp1Δ1, his3Δ200, leu2Δ1

Jiang et al., 1997

FGY2 (crd1Δ)

MAT α, ura3‐52, lys2‐801, ade2‐101, trp1Δ1, his3Δ200, leu2Δ1, crd1Δ::URA3

Jiang et al., 1997

FGY3 atg8Δ

Derivative of FGY3, atg8Δ::KanMX4

This study

FGY2 atg8Δ

Derivative of FGY2, atg8Δ::KanMX4

This study

FGY3 atg18Δ

Derivative of FGY3, atg18Δ::KanMX4

This study

FGY2 atg18Δ

Derivative of FGY2, atg18Δ::KanMX4

This study

FGY3 atg32Δ

Derivative of FGY3, atg32Δ::KanMX4

This study

FGY2 atg32Δ

Derivative of FGY2, atg32Δ::KanMX4

This study

FGY3 atg21Δ

Derivative of FGY3, atg21Δ::TRP1

This study

FGY3 atg18Δatg21Δ

Derivative of FGY3, atg18Δ::KanMX4, atg21Δ::TRP1

This study

FGY2 atg18Δatg21Δ

Derivative of FGY2, atg18Δ::KanMX4, atg21Δ::TRP1

This study

FGY3‐IDH1‐GFP

Derivative of FGY3, in which GFP is inserted into the IDH1 gene locus

This study

FGY2‐IDH1‐GFP

Derivative of FGY2, in which GFP is inserted into the IDH1 gene locus

This study

BY4742

MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0

Euroscarf a

VGY1 (BY4742 crd1Δ)

MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, crd1Δ::URA3

BY4742‐IDH1‐GFP

Derivative of BY4742, in which GFP is Inserted into the IDH1 gene locus

This study

BY4742 crd1Δ-IDH1‐GFP

Derivative of BY4742 crd1Δ::KanMX4, in which GFP is Inserted into the IDH1

This study

(Gohil et al., 2005)

gene locus
pFA6a‐GFP(S65T)‐His3MX6

Derivative of pFA6a‐ His3MX6

Kanki et al., 2009a

pCu416‐IDP1‐GFP

Derivative of pCu416, expresses GFP‐tagged IDP1 from CUP1 promoter

(Journo et al., 2009)

a

Euroscarf, European Saccharomyces cerevisiae Archive for Functional analysis.
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Table 2.2 Real-time PCR primers used in Chapter 2
Gene

Primers

Sequence

Forward

TCGTGCTGTCTTCCCATCTATCG

Reverse

CGAATTGAGAGTTGCCCCAGAAG

Forward

ACCTTACCGTAGGGCAATTTG

Reverse

CCCGTCCTTATCCTTGTGTTC

ACT1

ATG8
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FM 4-64 and quinacrine staining
FM 4-64 staining was performed as previously described (Conboy and Cyert,
2000) with minor revisions. Cell aliquots equivalent to an A550 of 1.0 were harvested by
centrifugation, resuspended in 100 μl YPD, and incubated at 37˚C or 39˚C with 0.16
mM FM4-64 for 15 min. Cells were pelleted and washed once with 37˚C YPD or 39˚C
YPD and then resuspended in 500 μl YPD of the same temperature for 30 min. The
cell suspension was centrifuged and the supernatants were discarded. The cell pellets
were resuspended in 100 μl YPD, from which 3 μl were applied to the microscope slide
and observed using epifluorescence microscopy using the filter for red fluorescence.
Quinacrine staining was performed as previously described (Roberts et al., 1991),
with minor revisions. Cell aliquots equivalent to an A550 of 1.0 were harvested by
centrifugation and resuspended in 500 μl YPD (containing 2 mM quinacrine and
buffered to pH 7.6 with 0.5M Na2HPO4) prewarmed to 37˚C or 39˚C. After a 5 min
incubation, cells were pelleted and washed once with 500 μl 2% glucose that had been
buffered to pH 7.6 with 0.5M Na2HPO4. The cell suspension was pelleted again and
resuspended in 100 μl 2% glucose at pH 7.6, from which 3 μl were applied to a
microscope slide and observed using epifluorescence microscopy using the filter for
green fluorescence.

Detection of mitophagy using fluorescence microscopy
Microscopic analyses were performed using an Olympus BX41 epifluorescence
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microscope. Images were captured by an Olympus Q-Color3 digital charge-coupled
device camera operated by QCapture2 software. All pictures were taken at a
magnification of 1000X. To induce mitophagy, cells expressing IDH1- GFP were
cultured in SC medium to the mid-log phase, pelleted and resuspended in 5 ml SL
medium with a starting A550 of 0.5. They were then cultured for 18 hours and observed
using epifluorescence microscopy. An increase in the signal of mito-GFP in the vacuole
indicated induction of mitophagy. In addition, cells were also treated with elevated
temperature. Both WT-IDH1-GFP and crd1Δ-IDH1-GFP were cultured in YPD medium
to the mid-log phase at 30˚C and then switched to 39˚C for 8 hours. Cells were then
observed using epifluorescence microscopy, using the filter for green fluorescence.

Western blot
Whole cell extracts were prepared as previously described (Kanki et al., 2009a)
with minor changes. Cell pellets equivalent to 1.5 A550 units were collected and
resuspended in 1 ml 10% trichloroacetic acid (TCA). Samples were incubated for 10
min on ice and proteins were pelleted by centrifugation at 4˚C, 15,000 rpm for 10 min.
The pellets were washed twice with 1 ml of ice-cold acetone and air-dried at room
temperature. The air-dried cell pellets were resuspended in 75 μl sample buffer, which
consisted of 150 mM Tris-HCl with pH 8.8, 6% SDS, 25% glycerol, 6 mM EDTA, and
disrupted by vortexing for 3 min in the presence of 75 μl acid-washed glass beads.
Following this step, the samples were heated at 100°C for 3 min and then centrifuged
at 4˚C, 7,000 rpm for 30 s to pellet the glass beads. 18 μl of the supernatants that
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contained the proteins were mixed with 6 μl 4X loading dye (80% bromophenol blue
and 20% β-mercaptoethanol) and loaded into a 12% SDS-polyacrylamide gel for
electrophoresis. The proteins were then transferred to a PVDF membrane with 0.2 μm
pores following the standard semidry Western blot transfer procedure. After blotting in
TBST-milk (TBS containing 1% TWEEN 20 and 0.5% milk), the membranes were
incubated in TBST-milk with mouse anti-YFP monoclonal antibody (JL-8, Clontech) at
a 1:3000 dilution at 4°C overnight. After washing with TBST (TBS containing 1%
TWEEN 20) for 4 times, 8 min per time, the membranes were incubated in 0.5% TBSTmilk with the secondary antibody, HRP-conjugated goat anti-mouse IgG (Santa Cruz),
at a 1:5000 dilution for 1 h at room temperature. After washing with TBST 4 more times,
8 min per time, the membrane was covered with Pierce™ ECL Plus Western Blotting
Substrate reagent. To detect the signal of GFP, the HyBlot ES® Autoradiography film
was exposed to the PVDF membrane and then developed. Idh1-GFP and cleaved GFP
were detected as bands of 68 kDa and 28 kDa, respectively.

Real-Time PCR (RT-PCR)
Both WT-IDH1-GFP and crd1Δ-IDH1-GFP strains in the FGY background were
cultured in 10 ml YPD medium to the mid-log phase at 30˚C and then switched to
39˚C for 8 hours. Cells were harvested and total RNA was extracted using the RNeasy
Mini kit (QIAGEN). This procedure removed possible contaminating genomic DNA.
cDNAs were synthesized using the Transcriptor First Strand cDNA synthesis kit
(Roche Diagnostics) following the manufacturer’s protocol. RT-PCR was performed
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in a 96-well plate using Brilliant III Ultra-Fast SYBR Green QPCR Master Mix (Agilent
Technologies). Duplicates for each sample were included. The primers used for RTPCR are listed in Table 2.2. ACT1 was used as the internal control. The mRNA level
of the target gene was normalized to ACT1 mRNA levels. PCR reactions were
performed at 95°C for 10 min for denaturation and then 40 cycles that consisted of 30
s at 95°C and 60 s at 56°C.
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Results
Deletion

of

autophagy/mitophagy

genes

exacerbates

the

temperature

sensitivity of crd1Δ
Previous studies have shown that loss of CL leads to impaired mitochondrial
function, including defective respiration (Schlame and Ren, 2006), decreased
mitochondrial membrane potential (Jiang et al., 2000) and impaired mitochondrial
protein import (Gebert et al., 2009; Jiang et al., 2000). It is known that mitophagy
increases as an adaptive and protective strategy in response to damage of
mitochondria to eliminate damaged organelles (Frank et al., 2012; Narendra et al.,
2008). A previous study in our lab found that, at elevated temperature, CL mutants
exhibit not only growth defects but also vacuole defects characterized by enlarged
vacuoles and loss of vacuole acidification (Chen et al., 2008b). The mechanism
underlying the vacuole defects in the CL mutants are unknown. Because increased
autophagy leads to a large influx of membrane and contents to the vacuole, resulting
in increased vacuole size (Baba M et al., 1994; Baba et al., 1995; Takeshige K et al.,
1992), I originally hypothesized that loss of CL might lead to increased mitophagy to
eliminate the damaged mitochondria at elevated temperature. In addition, my
preliminary study found that deletion of UTH1, a gene that is involved in cell wall
biogenesis and may play a role in mitophagy, rescued both the vacuole defects and
the temperature sensitivity of crd1Δ (Fig. 2.1), seeming to support my hypothesis that
the vacuole defects in the CL mutants may be due to increased mitophagy.
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To test this hypothesis, I decided to determine if there was genetic interaction
between CRD1 and autophagy/mitophagy genes. The rationale for this is that,
deletion of autophagy/mitophagy genes should block excessive mitophagy and
rescue the phenotype of crd1Δ. I constructed single mutants of mitophagy genes in
the FGY background, including atg8Δ, atg18Δ, atg21Δ, atg32Δ, double mutants of
crd1Δ and atg8Δ, atg18Δ, atg21Δ, atg32Δ, and the triple mutant crd1Δatg18Δatg21Δ.
Temperature sensitivity of these strains was examined. Surprisingly, deletion of
autophagy/mitophagy genes did not rescue (Fig. 2.2) but rather exacerbated the
temperature sensitivity of crd1Δ (Fig. 2.3). Compared to deletion of the mitophagyspecific gene ATG32, deletion of general autophagy genes, including ATG8 and
ATG18, caused more severe exacerbation of crd1Δ temperature sensitivity. These
findings suggested that mitophagy may be decreased in crd1Δ.

Delivery of mitochondria to the vacuole in response to increased temperature
is inhibited in crd1Δ
WT-IDH1-GFP and crd1Δ-IDH1-GFP strains in the FGY background were
constructed as described in the ‘Methods and materials’ section (Fig. 2.4). These
strains express an endogenous Idh1 protein that is tagged with GFP at the C terminus
and is localized in mitochondria. After culture in YPD medium to the mid-log phase at
30˚C, WT-IDH1-GFP and crd1Δ-IDH1-GFP were switched to 39˚C for 8 hours. Cells
were then observed using epifluorescence microscopy. Accumulation of GFP was
observed in the vacuole of WT cells, suggesting that elevated temperature
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Fig. 2.4 Insertion of GFP into the IDH1 gene locus.
Strains expressing an endogenous Idh1 protein tagged
with GFP at the C terminus were constructed as described
in the ‘Methods and materials’ section.
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induced delivery of Idh1-GFP tagged mitochondria into the vacuole of WT cells for
degradation. However, translocation of crd1Δ mitochondria into the vacuole was not
observed, suggesting that mitophagy was inhibited in crd1Δ cells (Fig. 2.5).
A recent study reported that transcription of ATG8 positively regulates the size of
the autophagosome (Backues et al., 2012) and reflects the extent of autophagy
induction (Gasch et al., 2000; Kirisako et al., 1999). When autophagy is triggered,
expression of ATG8 is induced more than 10-fold (Gasch et al., 2000; Kirisako et al.,
1999). Expression of ATG8 was determined in both WT and crd1Δ cells at 30˚C and
after switching to 39˚C for 8 hours. ATG8 mRNA levels in WT and crd1Δ were
comparable at 30˚C. Interestingly, ATG8 expression increased 3-fold in WT cells at
39˚C compared to that at 30˚C, while it increased 6.7-fold in crd1Δ cells at 39˚C
compared to that at 30˚C (Fig. 2.6). Expression of ATG8, the essential gene for
mitophagy and non-selective autophagy, was upregulated in both WT and crd1Δ at
elevated temperature. However, the increase was greater in crd1Δ than in WT cells,
suggesting that, in crd1Δ, there is a greater need to initiate mitophagy, or that nonselective autophagy may be upregulated to compensate for the decrease of mitophagy.

Induction of mitophagy is inhibited in crd1Δ cells
Based on the finding that the delivery of mitochondria into the vacuole is inhibited
in crd1Δ compared to WT in response to elevated temperature, I predicted that
mitophagy is decreased in crd1Δ compared to WT. Because elevated temperature has
not been previously shown to trigger mitophagy, and mitophagy has not been studied
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Fig. 2.5 Delivery of mitochondria to the vacuole in response to
increased temperature is inhibited in crd1Δ. WT and crd1Δ cells
expressing an endogenous Idh1 protein that is tagged with GFP at the
C terminus were cultured in YPD medium to the mid-log phase at
30˚C, shifted to 39˚C for 8 hours and observed using fluorescence
microscopy.
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Fig. 2.6 Increased temperature triggers increased upregulation of
ATG8 expression in crd1Δ cells. WT and crd1Δ cells were cultured in
YPD medium to the mid-log phase at 30˚C and divided into two groups:
one group was kept growing in 30˚C for 8 hours while the other group
was shifted to 39˚C for 8 hours. ATG8 expression was determined by
RT-PCR.
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in the FGY genetic background, I constructed WT-IDH1-GFP and crd1Δ-IDH1-GFP
strains in the BY4742 background, which is widely used in mitophagy studies (Kanki
et al., 2009b). WT-IDH1-GFP and crd1Δ-IDH1-GFP cells were cultured in SC medium
to the mid-log phase at 30˚C, harvested, washed twice and resuspended in SL medium,
which has been shown to induce mitophagy (Wu and Tu, 2011). After 18 hours, cells
were observed using epifluorescence microscopy. Similar to the result seen in the FGY
genetic background, accumulation of GFP was observed in the vacuole of WT but not
crd1Δ cells, suggesting that mitophagy is inhibited in crd1Δ (Fig 2.7 A). To exclude the
possibility that the observed differences were specific to the Idh1-GFP protein, I
constructed WT and crd1Δ strains that have the GFP-tagged mitochondrial protein
Idp1p exogenously expressed from the pCu416-IDP1-GFP plasmid. As seen in IDH1GFP strains (Fig 2.7 B), accumulation of Idp1-GFP was observed in the vacuole of the
WT but not crd1Δ cells, suggesting that mitophagy was inhibited in crd1Δ cells.
To confirm the microscopic finding, the release of free GFP from Idh1-GFP was
determined in WT-IDH1-GFP and crd1Δ-IDH1-GFP strains by Western blot. Cells were
cultured in SC medium to the mid-log phase at 30˚C, harvested, washed twice and
resuspended in SL medium. After 5, 6 or 7 hours, proteins were extracted as described
in the ‘Methods and materials’ section. As seen in Fig. 2.8, 6 hours after transferring to
SL medium, a GFP band was detectable in WT cells. In contrast, the signal from crd1Δ
cells was barely detectable. Taken together, these findings indicate that mitophagy is
inhibited in crd1Δ.
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A

DIC

Idh1-GFP

DIC

Idp1-GFP

WT

crd1Δ

B

WT

crd1Δ

Fig. 2.7 Decreased mitophagy in crd1Δ cells. WT and crd1Δ cells
expressing an endogenous Idh1-GFP (A) or exogenous Idp1-GFP (B)
were cultured in SC medium to the mid-log phase at 30˚C and shifted
to SL for 18 hours. Cells were observed using fluorescence
microscopy.
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0h
WT

6h

5h
crd1Δ

WT

crd1Δ

WT

7h
crd1Δ

WT

crd1Δ

Idh1-GFP

GFP

Fig. 2.8 Decreased mitophagy in crd1Δ cells expressing Idh1GFP. WT and crd1Δ cells carrying the GFP-tagged IDH1 gene were
pre-cultured in SC medium to the mid-log phase at 30˚C and shifted
to SL medium for 5, 6 or 7 hours. Aliquots were taken at the indicated
times. Immunoblotting was done with anti-YFP antibody and the
positions of full-length Idh1-GFP and free GFP are indicated.
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Discussion
In this chapter, I addressed the question of how loss of CL in the crd1Δ mutant
affects mitophagy. My findings indicate that CL deficiency leads to decreased
mitophagy. This conclusion is based on the findings that 1) deletion of
autophagy/mitophagy genes exacerbated crd1Δ growth defects, 2) GFP-tagged
mitochondria were not detected in the vacuole of crd1Δ in response to mitophagy
induction, and 3) in crd1Δ, there was decreased level of free GFP, which is cleaved
from Idh1-GFP after the mitochondria are delivered to the vacuole for degradation in
response to mitophagy induction.
The finding of decreased mitophagy seemed to contradict my preliminary finding
that deletion of UTH1 rescued both vacuole defects and temperature sensitivity in
crd1Δ. UTH1 was first linked to mitophagy by the finding that the uth1Δ mutant was
resistant to rapamycin, the inducer of autophagy (Camougrand et al., 2003). This was
further supported by the report of Kissova et al. (Kissová et al., 2004), which showed
loss of colocalization of mitochondria and vacuole in uth1Δ after rapamycin treatment.
However, Western analysis of degradation of mitochondria as determined by free GFP
was not carried out in this study. More recently, Uth1p was found on the mitochondrial
inner membrane, not in the outer membrane as previously predicted, and is
dispensable for post-log-phase and rapamycin-induced mitophagy (Welter et al., 2013).
Based on this recent finding, rescue of crd1Δ by deletion of UTH1 is unrelated to
mitophagy but more likely due to rescue of cell wall biogenesis defects, as CL mutants
exhibit defects in cell wall biogenesis and in maintenance of cell integrity (Zhong et al.,
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2005).
Interestingly, compared to deletion of the mitophagy specific gene, deletion of
general autophagy genes that are required in both nonselective autophagy and
mitophagy exacerbated crd1Δ growth defects to a more severe extent.

As seen in

Fig.2.3 A, crd1Δ is synthetically lethal with atg8Δ and atg18Δ. In contrast, crd1Δ is
synthetically sick with atg32Δ, as seen in Fig.2.3 B. The explanation for this may be
that CL is specifically involved in mitophagy, not nonselective autophagy. Thus,
nonselective autophagy may function normally in crd1Δ, and damaged mitochondria
may be delivered into vacuole for degradation as cargo in the nonselective
autophagosome. If nonselective autophagy is also blocked by deletion of ATG8 or
ATG18, cells will not be able to get rid of damaged mitochondria, resulting in cell death.
If mitophagy is further impaired by deletion of ATG32, damaged mitochondria may be
eliminated by nonselective autophagy, resulting in a sick but not lethal phenotype.
The possibility that nonselective autophagy in crd1Δ may not be compromised
may explain the greater increase in ATG8 gene expression in crd1Δ cells compared to
WT as seen in Fig. 2.6. Non-optimal growth temperatures likely result in a higher rate
of formation of aberrant mitochondria and respiratory-deficient petite mutants.
Furthermore, yeast mitochondrial protein synthesis is more thermolabile than
cytoplasmic protein synthesis (Walker, 1998). It has been reported that exposure to
elevated temperature induces mitochondrial swelling (Ma et al., 2004). These factors
may account for increased ATG8 expression and mitophagy at elevated temperature
in WT. When CL mutants are exposed to elevated temperature, mitochondrial swelling

46

may be more pronounced than in WT cells (Ma et al., 2004). Thus, it is reasonable to
speculate that increased ATG8 expression in crd1Δ is necessary to increase
mitophagy in order to eliminate damaged mitochondria. Another possibility is that
crd1Δ cells upregulate nonselective autophagy to a greater extent than WT cells to
compensate for decreased mitophagy.
In summary, studies in this chapter suggest that loss of CL may lead to
decreased mitophagy, which may account at least in part for the temperature sensitivity
of the crd1Δ mutant. Previous studies indicate that the PKC and HOG MAPK pathways
are required for mitophagy (Mao et al., 2011). To understand the underlying mechanism
of decreased mitophagy in crd1Δ, I carried out targeted genetic interaction analysis
between CRD1 and the genes of the MAPK pathways, which is described in Chapter
3. The findings in this chapter provide novel insights into the cellular functions of CL
outside of mitochondria.

.
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CHAPTER 3
DEFECTIVE MITOPHAGY IN crd1Δ MAY RESULT FROM DECREASED MAPK
PATHWAYS
Introduction
The studies described in Chapter Two suggest that perturbation of CL synthesis
leads to defective mitophagy. Mitophagy is regulated by different pathways from those
that control nonselective autophagy. Nonselective autophagy is regulated by at least
four signaling pathways, including the Ras/cAMP-dependent protein kinase A (PKA)
(Budovskaya et al., 2004; Zhou et al., 2009), the target of rapamycin (TOR) (Li et al.,
2012; Yorimitsu et al., 2007), Sch9 (Li et al., 2012; Yorimitsu et al., 2007) and Pho85
pathways. Mitophagy is specifically regulated by two MAPK pathways: the PKC and
HOG pathways (Li et al., 2012; Mao et al., 2011). The studies described in this chapter
were undertaken to determine if these MAPK pathways are affected by the loss of CL,
and if defective mitophagy in crd1Δ is due to altered PKC and HOG pathways.
PKC is a MAPK pathway that regulates cell wall integrity in yeast. Cell wall
integrity signaling is induced in response to various environmental stimuli, including
heat stress, hypo-osmotic shock, mating pheromone, and agents that cause cell wall
stress (Herskowitz, 1995; Levin and Errede, 1995). Wsc1p and Mid2p are plasma
membrane sensors that trigger Pkc1p, which conveys the signal downstream to Bck1p,
Mkk1p/ Mkk2p and Slt2p through a kinase cascade (Heinisch et al., 1999) (Fig. 3.1).
In response to induction of mitophagy, Slt2p is dually phosphorylated on threonine and
tyrosine residues (Mao et al., 2011). Deletion of the PKC pathway genes BCK1,
MKK1/MKK2, and SLT2 leads to defective mitophagy, suggesting the involvement of
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the PKC pathway in mitophagy. However, deletion of RLM1 and SWI4, genes encoding
the downstream effectors of phosphorylated Slt2p (pSlt2p), does not alter mitophagy
in WT cells. In addition, pSlt2p remains in the cytosol during mitophagy, suggesting
that, other than conveying the signal downstream, pSlt2p may directly play a role in a
relatively early stage of mitophagy (Fig. 3.1). As described in Chapter 2, mitophagy is
inhibited in crd1Δ, but the mechanism underlying the inhibition is not understood. The
finding that loss of PG, the precursor of CL, leads to defective activation of the PKC
pathway (Zhong et al., 2007) provides a clue to the potential mechanism underlying
inhibited mitophagy in crd1Δ. It is necessary to investigate if CL is required for PKC
pathway activation and further regulation of mitophagy.
The HOG pathway is a MAPK pathway that mediates the cellular response to
osmotic stress. It consists of two stress sensing branches, SLN1 and SHO1 (Saito and
Tatebayashi, 2004). While both branches are triggered by osmotic stress, only the
SHO1 signaling is triggered by heat stress (Winkler et al., 2002). Sln1p and Sho1p are
transmembrane osmosensors located within the plasma membrane. In response to
osmotic stress, Sln1p conveys the signal downstream to Ypd1p, Ssk1p and
Ssk2p/Ssk22p. In response to either osmotic or heat stress, Sho1p conveys the signal
to Cdc42p, Ste20p and Ste11p/Ste50p. The MAPKKKs Ssk2p/Ssk22p and Ste11p
trigger the same downstream MAPKK, Pbs2p. The MAPK Hog1p is dually
phosphorylated by activated Pbs2p (Fig. 3.1). When Hog1p is phosphorylated, it
translocates into the nucleus and induces transcription of up to 600 genes for cellular
adaptation to stress, including the genes that function in the synthesis of glycerol
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Fig. 3.1 The PKC and HOG pathways regulate different stages of
mitophagy. Revised from Mao et al. 2011.
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(O'Rourke and Herskowitz, 2004). Alternatively, phosphorylated Hog1p (pHog1p)
remains in the cytosol under certain conditions, including high temperature and
mitophagy induction (Mao et al., 2011; Winkler et al., 2002). Deletion of HOG1, PBS2
and SSK1, leads to defective mitophagy, suggesting the involvement of the SLN1
signaling of the HOG pathway in mitophagy. However, deletion of SKO1, HOT1 and
SMP1, genes encoding the downstream effectors of pHog1p, does not alter mitophagy
in WT cells (Mao et al., 2011). In addition, Hog1 is phosphorylated and remains in the
cytosol after induction of mitophagy, suggesting that pHog1p may directly play a role
in the cytosol at a relatively late stage of mitophagy (Fig. 3.1). As described in Chapter
2, mitophagy is inhibited in crd1Δ. Thus, it is necessary to investigate if the HOG
pathway is perturbed in crd1Δ.
In the studies described in this chapter, I investigated the effect of CL deficiency
on the HOG and PKC pathways. This study suggests that both pathways are defective
when there is a loss of CL. Interestingly, upregulation of the PKC pathway rescues
mitophagy in crd1Δ, indicating that decreased mitophagy in crd1Δ may result from an
impaired PKC pathway.
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Methods and materials
Yeast strains and growth media
The Saccharomyces cerevisiae strains used in this work are listed in Table 3.1.
Yeast extract peptone dextrose (YPD) medium, synthetic complete (SC) medium,
synthetic drop-out medium (SC ura-, SC leu-) and synthetic lactate (SL) medium were
described in Chapter Two. YPDS medium was YPD medium supplemented with 1 M
sorbitol. Sporulation medium contained potassium acetate (1%), glucose (0.05%), and
essential amino acids. Solid medium contained agar (2%) for solidification.

Construction of deletion mutants
An established MATα crd1Δ mutant with CRD1 replaced by the dominant
selectable marker URA3 was used as the query strain. Single mutants that have a
single HOG pathway gene deleted were obtained from the deletion collection
generated in the BY4741 (MATa) background (Research Genetics). The gene mutated
in each strain was replaced by a kanamycin (geneticin) resistance marker (KanMX4).
After crd1Δ was mated with each of these deletion strains, diploids were selected on
SC met- lys- double drop-out medium, and sporulation was induced on sporulation
medium. Double mutant meiotic progeny were selected on SC ura- drop-out medium
with 200 mg/liter geneticin, as described (Tong et al., 2001). Growth of the double
mutants was examined at various temperatures to identify genetic interactions
between CRD1 and the HOG pathway genes.
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Table 3.1 Yeast strains used in Chapter 3
Strain/plasmid

Characteristics or genotype

Source or reference
Euroscarf a

BY4742 (WT)

MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0

VGY1 (BY4742 crd1Δ)

Derivative of BY4742 , crd1Δ::URA3

BY4742 sho1Δ

Derivative of BY4742, sho1Δ:: KanMX4

This study

VGY1sho1Δ

Derivative of BY4742, crd1Δ::URA3, sho1Δ::KanMX4

This study

BY4742 ssk1Δ

Derivative of BY4742, ssk1Δ:: KanMX4

This study

VGY1ssk1Δ

Derivative of BY4742, crd1Δ::URA3, ssk1Δ::KanMX4

This study

BY4742 ste50Δ

Derivative of BY4742, ste50Δ::KanMX4

This study

VGY1ste50Δ

Derivative of BY4742, crd1Δ::URA3, ste50Δ::KanMX4

This study

BY4742 hog1Δ

Derivative of BY4742, hog1Δ::KAN

This study

VGY1hog1Δ

Derivative of BY4742, crd1Δ::URA3, hog1Δ::KanMX4

This study

BY4742 WT‐IDH1‐GFP

Derivative of BY4742, in which IDH1 gene is chromosomally tagged with GFP

This study

BY4742 crd1Δ- IDH1‐GFP

Derivative of BY4742 crd1Δ::KanMX4, in which IDH1 gene is chromosomally

This study

(Gohil et al., 2005)

tagged with GFP
pYPGK18

2μm, LEU2

pYPGK18‐PTP2

Derivative of pYPGK18, expresses PTP2 from PGK1 promoter

This study

pYPGK18‐PTP3

Derivative of pYPGK18, expresses PTP3 from PGK1 promoter

This study

pYCp50

CEN, URA3

pYCp50‐PKC1

R398P

Derivative of pYCp50, expresses PKC1

(Vaz et al., 2003)

(Helliwell et al., 1998)
R398P

from PGK1 promoter

(Helliwell et al., 1998)

pRS352

2μm, URA3

(Helliwell et al., 1998)

pRS352‐BCK1‐20

Derivative of pRS352, expresses BCK1‐20 from PGK1 promoter

(Helliwell et al., 1998)

pPS1739‐HOG1‐GFP

CEN, URA3, HOG1‐GFP

(Ferrigno et al., 1998)
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Plasmid construction
To construct the PTP2 overexpression plasmid, a sequence of 2250 base pairs
that contains the entire open reading frame of PTP2 was amplified from yeast genomic
DNA

using

KpnI-tagged

forward

primer

PTP2fr-f

(5’-GG

GGTACCATTGATGGATCGCATAGCACAG-3’) and XbaI-tagged reverse primer
PTP2fr-r (5’- CGC TCTAGA TTAACAAGGTAACGCGTTCTTTATC -3’). After being cut
by the restriction enzyme KpnI and XbaI, the PCR product was ligated downstream of
the PGK1 promoter on the pYPGK18 (2um, LEU2) plasmid (Fig 3.2).
To construct the PTP3 overexpression plasmid, a sequence of 2751 base pairs
that contains the entire open reading frame of PTP3 was amplified from yeast genomic
DNA

using

EcoRI-tagged

forward

primer

PTP3fr-f

(5’-CCGGAATTC

GAACATGAAGGACAGTGTAGACTGC-3’) and BamHI-tagged reverse primer PTP3frr (5’-CGCGGATCCGCCTAACTATTGTGGCAATTCTTTC-3’). After being cut by the
restriction enzyme KpnI and XbaI, the PCR product was ligated downstream of the
PGK1 promoter on the pYPGK18 (2um, LEU2) plasmid (Fig 3.2).

Single colony formation and spotting
Single colony formation experiments were performed as described in Chapter
Two.
Spotting experiments were performed as follows. Cells were pre-cultured in SC
drop-out liquid medium at 30˚C to the mid-log phase. The A550 of the cells was
determined using a spectrometer (Beckman). Cell aliquots were centrifuged and
pellets were resuspended in SC leu- medium adjusted to an A550 of 10 units per ml. A
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Fig. 3.2 Construction of the pYPGK18-PTP2 and pYPGK18-PTP3
overexpression plasmids. The detailed procedure was described
in the ‘Methods and materials’ section.
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100X diluted sample was added onto a hemocytometer for cell counting using light
microscopy. Based on the cell counting result, cell aliquots were adjusted to 2x108
cells/ml. The cell aliquots were then diluted in a 10X serial dilution. Cells were spotted
on SC drop-out plates with the most diluted spot containing 2000 cells and the plates
were incubated at experimental temperatures for 2 days. The appearance of visible
growth at various temperatures was evaluated.

Fluorescence and microscopic analysis
Microscopic analysis was performed using an Olympus BX41 epifluorescence
microscope. Images were captured by an Olympus Q-Color3 digital charge-coupled
camera operated by QCapture2 software. All pictures were taken at 1000x
magnification.
The method used to detect mitophagy by monitoring the translocation of GFPtagged mitochondria was described in Chapter Two. The same procedure was
performed in BY4742 WT-IDH1-GFP and crd1Δ-IDH1-GFP strains that were
transformed with either pYcp50 empty vector or pYcp50::PKC1R398, which
overexpresses a constitutively activated Pkc1p.
To visualize the translocation of phosphorylated Hog1p, WT and crd1Δ cells in
the BY4742 background were transformed with the pPS1739 plasmid, which
expresses HOG1-GFP (kindly provided by Dr. Pamela Silver, Harvard Medical School).
Transformants were cultured in SC ura- liquid medium and grown to an A550 of 1.0. The
cells were treated with different conditions (39°C or 0.5 M NaCl) and observed using
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epifluorescence microscopy using a green fluorescence filter. Translocation of
phosphorylated Hog1p was determined by the accumulation of GFP inside the nucleus.

Western blot
Western blot analysis to detect Idh1-GFP and cleaved free GFP was described
in Chapter Two.
To detect Slt2p and pSlt2p by Western blot, whole cell extracts were prepared
as previously described (Hoppins et al., 2011) with minor changes. Mid-log phase cells
were diluted to an A550 of 0.3 and grown at 30°C or 39°C. After culture at different
temperatures for 2 hours, cells at an A550 of 1 were collected, washed with 1 ml icecold sterile water and resuspended in 1 ml 0.255 M NaOH BME buffer, which consisted
of 0.255 M NaOH, 1% β-mercaptoethanol, and 0.86 ml sterile distilled water. The
samples were incubated for 10 min on ice and 138 μl 72% TCA were added. The
samples were incubated on ice for another 10 min and then pelleted by centrifugation
at 4˚C, 15000 rpm for 10 min. The pellets were washed once with 500 μl of ice-cold
acetone, spun down at 4˚C, 15000 rpm for 5 min and then air-dried at room
temperature. The air-dried cell pellets were resuspended in 50 μl MURB buffer, which
consisted of 100 mM MES (PH 7.0), 1% SDS, 3 M urea, 10% β–ME and 35 μl ddH2O.
9 μl of each sample were mixed with 3 μl 4X loading dye (80% bromophenol blue and
20% β-mercaptoethanol) and loaded into a 10% SDS-polyacrylamide gel for
electrophoresis. The transferring and blotting steps were described in Chapter Two.
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The primary and secondary antibodies used to recognize dually phosphorylated pSlt2p
and total Slt2p are listed in Table 3.2.
To detect Hog1p and pHog1p by Western blot, whole cell extracts were prepared
as described (Li et al., 2012). The primary and secondary antibodies used to recognize
phosphorylated pHog1p and total Hog1p are listed in Table 3.2.
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Table 3.2 Antibodies used in determining MAPK pathway activation
Protein

Primary Antibody
anti-phospho-p44/42
MAPK (Thr202/Tyr204)
mouse IgG
( Cell signaling)

Secondary Antibody
HRP-conjugated goat
anti-mouse IgG
( Santa Cruz)

Slt2p

anti-Slt2p goat IgG
(Santa Cruz)

HRP-conjugated donkey
anti-goat IgG
( Santa Cruz)

1 band
~ 55 kDa

pHog1p

anti-phospho-p38 rabbit
IgG (antibody 3D7; Cell
Signaling)

HRP-conjugated goat
anti-rabbit IgG
( Santa Cruz)

1 band
~ 49 kDa

Hog1p

anti-Hog1p goat IgG
(antibody yC-20, Santa
Cruz)

HRP-conjugated donkey
anti-goat IgG
( Santa Cruz)

1 band
~ 49 kDa

pSlt2p

Band size
2 bands
~ 55 kDa
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Results
Down-regulation of the HOG pathway exacerbates the crd1Δ growth defect.
In Chapter Two, I reported that, under mitophagy inducing conditions, crd1Δ
exhibited decreased mitophagy compared to WT. The HOG pathway is an upstream
regulator of mitophagy. Deletion of the HOG pathway genes HOG1 and PBS2 leads to
defective mitophagy (Mao et al., 2011). pHog1p appears to stay in the cytosol to play
a role in a relatively late stage of mitophagy. Thus, I investigated the possibility that the
HOG pathway is perturbed in crd1Δ.
For this purpose, I determined if there is genetic interaction between CRD1 and
HOG pathway genes. The yeast deletion collection facilitated construction of double
mutants (Tong et al., 2001). crd1Δ was mated with sho1Δ, ssk1Δ, ste50Δ and hog1Δ
mutants. Tetrads were obtained subsequent to sporulation, and haploids were
acquired via tetrad dissection. Haploids containing mutations in both CRD1 and one of
the four HOG pathway genes were selected by uracil prototrophy (crd1Δ mutation) and
geneticin resistance (HOG pathway mutation). crd1Δ in the BY4742 background
cannot form colonies from single cells plated on YPD at 40°C, which is a permissive
temperature for WT (Jiang et al., 1999; Zhong et al., 2004). At 38˚C and 39˚C, crd1Δ
cells form smaller colonies than WT. Based on this growth phenotype, genetic
interaction was assessed at elevated temperature. Growth of double mutants at 40°C
was considered rescue of the crd1Δ growth defect, while inability to grow at 38˚C or
39˚C indicated exacerbation of the crd1Δ growth defect.
While crd1Δ cells formed colonies at 39˚C, crd1Δssk1Δ did not. crd1Δste50Δ,
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crd1Δsho1Δ, crd1Δhog1Δ did not form colonies even at 38˚C (Fig. 3.3), suggesting
that mutants of SSK1, STE50, SHO1, and HOG1 genetically interact with crd1Δ. To
determine if down-regulation of the HOG pathway leads to exacerbation of the crd1Δ
growth defect, PTP2 and PTP3, which negatively regulate the HOG pathway, were
overexpressed in crd1Δ. Serial diluted crd1Δ cells containing empty vector or
overexpressing PTP2 or PTP3 were spotted on leu- plates and incubated at 30˚C 38˚C. The growth defect of crd1Δ was exacerbated by overexpression of PTP2 and
PTP3 (Fig. 3.4). These data suggest that downregulation of the HOG pathway leads
to exacerbation of the crd1Δ growth defect, and the HOG pathway may be perturbed
in crd1Δ.

Loss of CL leads to decreased Hog1p phosphorylation without perturbing
activated Hog1p translocation
Downregulation of the HOG pathway leads to exacerbation of the crd1Δ growth
defect, suggesting that the HOG pathway may be altered in crd1Δ cells. To determine
if Hog1p phosphorylation is perturbed in crd1Δ, I induced Hog1p activation with 0.5 M
NaCl for 5 min, and analyzed Hog1p phosphorylation by Western blot, using a
monoclonal antibody against dually phosphorylated p38, as described (Li et al., 2012;
Zhou et al., 2009). Compared to WT cells, Hog1p activation was decreased in crd1Δ
in response to osmotic stress (Fig. 3.5 A). To determine if translocation of activated
Hog1p was perturbed in crd1Δ, WT and crd1Δ cells were transformed with the
pPS1739 plasmid containing HOG1-GFP. The cells were cultured in SC ura- liquid
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Fig. 3.3 Deletion of HOG pathway genes is synthetically
lethal with CRD1 deletion. Cells were pre-cultured in liquid
YPD at 30˚C to the mid-log phase. 200 cells of each strain
were plated on YPD plates and incubated at 38˚C or 39˚C for
3 days.
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crd1Δ‐vector

crd1Δ‐PTP2

crd1Δ‐PTP3

30˚C

36˚C

37˚C

38˚C

Fig. 3.4 Overexpression of the negative regulators of the HOG
pathway is synthetically lethal with CRD1 deletion. Cells were precultured in liquid SC leu- at 30˚C to the mid-log phase. Cell aliquots were
adjusted to 2x108 cells/ml and then diluted in a 10X serial dilution. Cells
were spotted on SC leu- plates with the most diluted spot containing 2000
cells, and the plates were incubated at 30˚C, 36˚C, 37˚C or 38˚C for 2
days.
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medium to an A550 of 1 and treated with 0.5 M NaCl for 5 min. Fluorescence microscopy
showed no difference between WT and crd1Δ in the translocation of activated Hog1p
after NaCl treatment (Fig. 3.5 B).

Heat stress does not activate Hog1p in WT and does not rescue decreased
Hog1p phosphorylation in crd1Δ
Both branches of the HOG pathway are triggered by activation of the
corresponding membrane-bound sensors (Sho1p or Sln1p) in response to osmotic
stress. A previous publication has shown that heat stress triggers the HOG pathway
via the SHO1 but not the SLN1 signaling (Winkler A, 2002). Surprisingly, Hog1p
phosphorylation was not observed in WT or crd1Δ in response to heat stress (Fig. 3.6
A). The translocation of Hog1-GFP in response to heat stress was also not observed.
WT and crd1Δ cells containing the pPS1739 plasmid were pre-cultured in liquid YPD
at 30˚C to the mid-log phase, switched to 39˚C for 10 min and observed using
epifluorescence microscopy. Consistent with the Western blot result, the translocation
of Hog1-GFP into the nucleus was not observed in either WT or crd1Δ (Fig. 3.6 B),
suggesting that heat stress does not trigger Hog1p activation or translocation in the
BY4742 background.

Upregulation of the PKC pathway rescues the crd1Δ growth defect
As mentioned above, a previous study in yeast demonstrated that activation of
the PKC pathway is decreased in pgs1Δ (Zhong et al., 2007). Deletion of PGS1 causes
loss of both PG and CL. Thus, I investigated if there is decreased activation of PKC
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A
0.5 M NaCl
WT

crd1Δ

WT

crd1Δ

p-Hog1p
Hog1p

SC ura- 30˚C

B

WT

crd1Δ

SC ura- 30˚C + 0.5M NaCl
WT

crd1Δ

GFP

DC

Fig. 3.5 (A) Decreased Hog1p phosphorylation in the crd1Δ mutant. Cells
were pre-cultured in liquid YPD at 30˚C to the mid-log phase and treated with
0.5 M NaCl for 5 min. Dually phosphorylated Hog1p and total Hog1p protein
were detected by Western blot, as described previously (Zhou et al., 2009). (B)
Translocation of activated Hog1p is not affected in crd1Δ. WT and crd1Δ
were transformed with the plasmid pPS1739, from which Hog1p fused to GFP
was expressed. Cells were grown in SC ura- to an A550 of 1, treated with 0.5 M
NaCl for 5 min and then observed using epifluorescence microscopy.
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30˚C

39˚C

WT crd1Δ WT crd1Δ
p-Hog1p
Hog1p

B

SC ura- 30˚C
WT

crd1Δ

SC ura- 39˚C
WT

crd1Δ

GFP

DC

Fig. 3.6 (A) Heat stress does not trigger phosphorylation in the
BY4742 background. Cells were pre-cultured in YPD at 30˚C to the midlog phase and switched to 39˚C for 5 min. Dually phosphorylated Hog1p
and total Hog1p proteins were detected by Western blot, as described
previously (Zhou et al., 2009). (B) Heat stress does not induce the
translocation of GFP tagged Hog1p into the nucleus in the BY4742
background. WT and crd1Δ were transformed with the plasmid pPS1739,
on which HOG1 is fused to GFP. Cells were grown in SC ura- to an A550 of
1, switched to 39˚C, and observed using epifluorescence microscopy.
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pathway in crd1Δ, which has PG but not CL. For this purpose, I examined the activation
state (dual phosphorylation) of Slt2p in response to elevated temperature in isogenic
WT, crd1Δ and pgs1Δ cells in the BY4742 background by Western blot. Because
pgs1Δ in the FGY background requires sorbitol for survival at even 30°C, to exclude
any influence caused by sorbitol, I also determined the Slt2p phosphorylation in pgs1Δ
in this background, supplemented with 1 M sorbitol. Cells were pre-cultured in YPD at
30˚C to the mid-log phase, diluted to an A550 of 0.3, and grown at 30°C or 39˚C for 2
hours. Whole cell extracts were prepared, and dually phosphorylated Slt2p and total
Slt2p proteins were detected by Western blot, as described in the ‘Methods and
materials’ section. Dual phosphorylation of Slt2p in WT was detected after the cells
were cultured for 2 hours at 39˚C. Slt2p dual phosphorylation was decreased in crd1Δ
and almost absent in pgs1Δ and pgs1Δ supplemented with sorbitol, which indicates
decreased PKC pathway activation in the CL mutants (Fig. 3.7 A). To upregulate the
PKC pathway, crd1Δ was transformed with a vector expressing constitutively activated
Bck1 (BCK1-20) or Pkc1 (PKCR398P). Consistent with the Western blot result, spotting
experiments demonstrated that crd1Δ temperature sensitivity was rescued by plasmids
expressing constitutively activated Bck1 or Pkc1 (Fig. 3.7 B), suggesting that
upregulation of the PKC pathway rescues the crd1Δ growth defect.

Upregulation of the PKC pathway rescues defective mitophagy in crd1Δ
As mentioned above, activation of the PKC and HOG pathways are required for
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mitophagy (Mao et al., 2011). Therefore, I investigated a possible causal relationship
between decreased MAPK pathways and inhibited mitophagy in crd1Δ.
Upregulation of the PKC pathway was achieved in WT-IDH1-GFP and crd1ΔIDH1- GFP strains in the BY4742 background by transfecting the cells with plasmid
carrying the PCK1R398 gene, which encodes a constitutively activated Pkc1p. WTIDH1-GFP and crd1Δ-IDH1-GFP cells containing either empty vector or vector
expressing PCK1R398 were pre-cultured in liquid SC ura- medium, harvested, washed
twice, and resuspended in SL medium at a starting A550 of 0.5. After 18 hours, cells
were observed using epifluorescence microscopy. As predicted, accumulation of GFP
was observed in the vacuole of WT-IDH1-GFP cells containing either the empty vector
or vector expressing PKC1R398P. GFP accumulation was not observed in crd1Δ-IDH1GFP cells containing the empty vector. Interestingly, accumulation of GFP was
observed in crd1Δ-IDH1-GFP cells containing the vector that expresses the PKC1R398P
gene, suggesting that mitochondria were delivered into the vacuole of this strain (Fig.
3.8).
The release of free GFP, a byproduct of mitophagy, was determined by Western
blot of WT-IDH1-GFP and crd1Δ-IDH1-GFP strains containing either an empty vector
or a vector expressing PCK1R398. Cells were cultured in liquid SC ura- medium to the
mid-log phase at 30˚C, harvested, washed twice and resuspended in SL medium at a
starting A550 of 0.5. After 6 hours, proteins were extracted as described previously.
Consistent with the finding of the microscopic examination experiment, the Western
blot showed a strong free GFP band in WT cells containing either the empty vector or
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WT-EV

WT-PKC1

crd1Δ-EV

crd1Δ-PKC1

GFP

DC

Fig.3.8 Upregulation of the PKC pathway rescues the delivery of
mitochondria into vacuole in crd1Δ after induction of mitophagy.
WT-IDH1-GFP and crd1Δ-IDH1-GFP cells containing either an empty
vector or a vector expressing PKC1R398P were cultured in SC uramedium to the mid-log phase at 30˚C, washed and shifted to SL for 18
hours. Cells were then observed with fluorescence microscopy.
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the vector expressing PKC1R398P, but only a very faint free GFP band in crd1Δ-IDH1GFP containing the empty vector, indicating that mitophagy is defective in crd1Δ cells.
However, a strong free GFP band that is comparable to that detected in WT-ev and
WT-PKC strains was observed in crd1Δ-IDH1-GFP cells containing the vector that
expresses PKC1R398P, suggesting that PKC rescued mitophagy in this strain (Fig. 3.9).

The HOG pathway stimulants rescues the crd1Δ growth defect
A constitutively activated HOG pathway causes lethality, and cannot be used to
study mitophagy in crd1Δ. Although it is difficult to test if there is direct causal
relationship between a decreased HOG pathway and defective mitophagy in crd1Δ,
indirect evidence suggests that upregulating the HOG pathway may rescue the crd1Δ
growth defect. A previous study demonstrated that the addition of 1 M sorbitol, a HOG
pathway stimulant, rescued crd1Δ growth and vacuole defects (Chen et al., 2008b).
Our present study established that 200 mM NaCl, another HOG pathway activator,
similarly rescued crd1Δ temperature sensitivity (Fig. 3.10). However, more direct
evidence is needed to conclude that a decreased HOG pathway inhibits mitophagy in
crd1Δ.
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0h

6h

Idh1-GFP

GFP

Fig. 3.9 Upregulation of the PKC pathway rescues mitophagy in
crd1Δ. WT-IDH1-GFP and crd1Δ-IDH1-GFP cells containing either
an empty vector or a vector expressing PKC1R398P were cultured in
SC ura- medium to the mid-log phase at 30˚C, washed and shifted to
SL. Samples were taken before shift to SL medium and at 6 hours
post-shift. Immunoblotting was done with an anti-GFP antibody and
the positions of full-length Idh1-GFP and free GFP are as indicated.
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YPD

YPD+ 200 mM NaCl

WT

crd1Δ

Fig. 3.10 200 mM NaCl rescues crd1Δ temperature
sensitivity. WT and crd1Δ cells in the FGY background were
pre-cultured in YPD liquid at 30˚C to the mid-log phase. 200
cells were plated on a YPD plate with or without 200 mM NaCl.
Plates were then incubated at 37.5˚C for 3 days.
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Discussion
In this chapter, I addressed the hypothesis that loss of CL leads to perturbation
of the HOG and PKC pathways, which causes defective mitophagy in crd1Δ.
Consistent

with

this

hypothesis,

the

crd1Δ

mutant

exhibited

decreased

phosphorylation of Hog1p in the presence of osmotic stress and decreased
phosphorylation of Slt2p in the presence of heat stress, suggesting defective activation
of both the HOG and PKC pathways in crd1Δ. As expected, pgs1Δ treated with heat
stress also exhibited largely decreased phosphorylation of Slt2p. I demonstrated that
upregulation of the PKC pathway rescued the growth defect in crd1Δ, as well as the
accumulation of GFP labeled mitochondria and cleaved GFP in the vacuole of crd1ΔIDH1-GFP. This suggests that upregulation of the PKC pathway rescued mitophagy in
crd1Δ, supporting the hypothesis that defective mitophagy in crd1Δ may be due to
defective activation of the PKC pathway.
Based on the previous findings that crd1Δ exhibits defective activation of the
HOG pathway, which is required for mitophagy, upregulation of this pathway may
rescue mitophagy in crd1Δ. However, constitutive activation of the HOG pathway
causes cell lethality. It was previously shown that 1 M sorbitol, a HOG pathway
stimulant, rescues the crd1Δ growth and vacuole defects (Chen et al., 2008b). In
addition, I found that 200 mM NaCl, which also stimulates the HOG pathway, rescued
crd1Δ temperature sensitivity (Fig. 3.8). These findings provide a clue that upregulating
the HOG pathway may rescue the crd1Δ growth defect. However, sorbitol and NaCl
also regulate cellular ion homeostasis, which may account for rescue of crd1Δ defects.
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Although ion homeostasis may be perturbed in crd1Δ, it would not be the sole cause
of the growth defect, because upregulation of the PKC pathway, which does not affect
ion regulation, rescued the crd1Δ growth defect.
As mentioned in Chapter Two, there was very little free GFP detected by Western
blot in whole cell extracts from crd1Δ-IDH1-GFP after induction of mitophagy.
Consistent with this, the phosphorylation of Slt2p and Hog1p upon induction by heat
or osmotic stress was decreased but not fully blocked. Slt2p and Hog1p
phosphorylation was detectable after stimulation, which might explain the faint band of
free GFP detected in crd1Δ-IDH1-GFP cells 7 hours after mitophagy induction (Fig.
2.8). If the HOG pathway is fully blocked, the late stage of mitophagy may be disrupted.
Upregulation of the PKC pathway, which regulates the early stage of mitophagy, may
not rescue mitophagy in crd1Δ under these conditions.
Because crd1Δ is synthetically lethal with mutants of SLN1 and SHO1 branches,
decreased activation of both branches may occur in crd1Δ. To address this possibility,
Hog1p activation in double mutants with deletion of CRD1 and a gene from either
branch should be compared to that of crd1Δ. For example, if sho1Δ exacerbates the
Hog1p activation defect in crd1Δ, this would suggest that CL may be required for
activation of SLN1 signaling.
Translocation of pHog1p into the nucleus was not affected in crd1Δ cells.
Surprisingly, elevated temperature did not induce phosphorylation or the translocation
of Hog1p into the nucleus. This conflicts with the finding of Winkler, who reported that
heat stress induced Hog1p activation (Winkler et al., 2002), but it may be explained by
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the fact that our studies were performed using strains from different backgrounds. Heat
activation of the HOG pathway is likely to be strain dependent.
In summary, the studies described in this chapter suggest that the loss of CL may
lead to decreased PKC and HOG pathways, and that a defective PKC pathway may
account for impaired mitophagy in the crd1Δ mutant. The findings in this chapter
provide novel insights into the cellular function of CL. It is tempting to speculate that
upregulation of the PKC pathway may be a potential treatment strategy for BTHS
patients.
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CHAPTER 4

FUTURE DIRECTIONS

The studies described in this thesis provide novel insights into the cellular
functions of CL beyond the confines of mitochondria, including mitophagy and the PKC
and HOG pathways. While my studies showed that loss of CL leads to defective
mitophagy, which may be due to decreased function of MAPK pathways, much remains
to be unveiled. To elucidate the mechanism linking defective mitophagy and MAPK
pathways in CL-deficient cells, as well as the mechanism underlying the role of CL in
vacuolar morphology and acidification, future studies should address the following
questions:

1.

Does nonselective autophagy function normally in crd1Δ ?
In Chapter 2, I showed that CL deficiency leads to decreased levels of

mitochondria and cleaved GFP in the vacuole, suggesting defective mitophagy in
crd1Δ cells. However, deletion of ATG8 or ATG18, the general autophagy genes
required for both nonselective autophagy and mitophagy, exacerbated the crd1Δ
growth defect to a greater extent than deletion of the mitophagy specific gene, ATG32,
(Fig. 2.3). I hypothesize that CL is specifically required for mitophagy, not for
nonselective autophagy. Accordingly, if nonselective autophagy is unaffected in crd1Δ,
damaged mitochondria can be enclosed in nonselective autophagosomes and
delivered to the vacuole for degradation. However, if nonselective autophagy in crd1Δ
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is blocked by deletion of ATG8 or ATG18, the cell will not be able to remove damaged
mitochondria. This would result in cell death, consistent with synthetic lethality of crd1Δ
and atg8Δ. This hypothesis is further supported by the finding that expression of ATG8
in crd1Δ is two-fold higher than in WT at 39˚C (Fig. 2.6), suggesting that nonselective
autophagy is upregulated in crd1Δ.
If nonselective autophagy is functional in crd1Δ cells, stimulation by rapamycin
might be expected to rescue crd1Δ growth defects. To test this possibility, rapamycin
was added to YPD plates and temperature sensitivity of crd1Δ and WT in the FGY
background was examined at 36.5°C and 37°C. WT cells were unable to grow at
elevated temperature in the presence of rapamycin concentrations greater than 1 nM.
0.01-1 nM rapamycin did permit growth of WT cells, while 0.5 nM rapamycin induced
a slight rescue of crd1Δ temperature sensitivity at elevated temperature (data not
shown). Future experiments are necessary to explain why only 0.5 nM rapamycin
rescued crd1Δ growth defects. Rapamycin is an antifungal antibiotic, which inhibits the
target of rapamycin complex 1 (TOR1). In addition to negatively regulating autophagy
and transcription of stress responsive genes, TOR1 positively regulates ribosome
biogenesis, global translation initiation, and nutrient import. Thus, the effect of
rapamycin is like a double-edged sword: it increases autophagy while inhibiting
ribosome biogenesis, global translation initiation, and nutrient import, resulting in cell
lethality.

With additional growth defects, crd1Δ may be more sensitive to rapamycin

than WT. The toxicity of 0.5-1 nM rapamycin may overwhelm the benefits of increased
nonselective autophagy induced by these concentrations in crd1Δ. crd1Δ may tolerate
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rapamycin less than 0.5 nM. However, levels of nonselective autophagy triggered by
these concentrations may be inadequate to remove the majority of damaged
mitochondria. 0.5 nM rapamycin may be an optimal concentration that can trigger
enough nonselective autophagy to remove the majority of the damaged mitochondria.
To definitively ascertain if nonselective autophagy is functional in CL deficient
cells, direct monitoring of nonselective autophagy in crd1Δ is required. An engineered
protein Pho8Δ60 has been designed for this purpose (Noda and Klionsky, 2008).
Pho8Δ60 lacks the N-terminal transmembrane domain of Pho8 (alkaline phosphatase)
that targets the endoplasmic reticulum; thus, the mutated protein remains in the cytosol
and is only delivered to the vacuole through nonspecific autophagy. After entering the
vacuole lumen, the alkaline phosphatase activity of Pho8Δ60 is proteolytically
activated. Therefore, enzyme activity of Pho8Δ60 reflects the level of nonspecific
autophagy. To determine if nonselective autophagy is upregulated to compensate for
defective mitophagy in crd1Δ cells, the Pho8Δ60 assay should be performed.

2.

Which branch of the HOG pathway is defective in crd1Δ?

As described in Chapter 3, loss of CL leads to decreased Hog1p phosphorylation
without perturbing activated Hog1p translocation. However, it is not known if decreased
Hog1p phosphorylation is due to perturbation of the SHO1 or SLN1 branch, or perhaps
to both.
If loss of CL leads to defective SHO1 signaling, downregulating SLN1 signaling
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will exacerbate decreased Hog1p activation in crd1Δ. In this situation, with 0.5 M NaCl,
crd1Δssk1Δ (SSK1 is required for SLN1 signaling) should have less Hog1p activation
than crd1Δ, while crd1Δsho1Δ should have comparable Hog1p activation with crd1Δ.
If loss of CL leads to defective SLN1 signaling, downregulating SHO1 signaling will
exacerbate the decreased Hog1p activation in crd1Δ. In this situation, with 0.5 M NaCl,
crd1Δsho1Δ should have less Hog1p activation than crd1Δ, while crd1Δssk1Δ should
have comparable Hog1p activation with crd1Δ. However, if CL is required for activation
of both branches, then the Hog1p activation in both crd1Δsho1Δ and crd1Δssk1Δ will
be less than that of crd1Δ.
In summary, comparing Hog1p activation in crd1Δ, crd1Δsho1Δ and crd1Δssk1Δ
by Western blot should help to identify which HOG branch is defective in crd1Δ.

3.

How does sorbitol rescue crd1Δ growth and vacuole defects?
A previous study in our lab showed that 1 M sorbitol restores both growth and

vacuole defects in crd1Δ by a mechanism not yet identified (Chen et al., 2008b). As
shown in Fig. 4.1, 1 M sorbitol upregulates the HOG pathway at 39˚C, which might be
the mechanism underlying rescue of crd1Δ temperature sensitivity and vacuole defects
by sorbitol. However, the possibility that 1 M sorbitol restores the defects of crd1Δ via
stimulating other osmotic regulatory pathways is not excluded. To address this
question, my previous labmate Shuliang Chen and I carried out a targeted screen of
osmotic regulatory mutants to identify those that abrogated sorbitol-mediated rescue
of crd1Δ. Double mutants of CRD1 and the genes shown in Table 4.1 were constructed.
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YPD
WT

crd1Δ

0.5 M NaCl
WT

crd1Δ

1M sorbitol
WT

crd1Δ

p-Hog1p
39˚C
Hog1p

Fig. 4.1 1 M sorbitol induces Hog1p activation in crd1Δ at elevated
temperature. Cells were pre-cultured in YPD at 30˚C to mid-log phase
and switched to 39˚C for 5 min and at the same time treated with either
0.5 M NaCl (positive control) or 1 M sorbitol. The dually phosphorylated
Hog1p and total Hog1p proteins were detected by Western blot, as
described previously (Zhou et al., 2009).

81

Failure of sorbitol to rescue the double mutant indicated that the query gene is required
for sorbitol-mediated rescue of crd1Δ.
A search of the Saccharomyces Genome Database identified 57 nonessential
genes that are involved in the HOG or other osmotic stress pathways (Table 4.1). A
targeted synthetic genetic array (SGA) was performed as described (Zhou et al., 2009).
Single mutants of the stress response genes were mated with crd1Δ, diploids were
sporulated, and progeny containing mutations in both CRD1 and each of the query
genes were selected by geneticin resistance (mutation of the query gene) and uracil
prototrophy (CRD1 mutation). Double mutants were confirmed by PCR.
Four of the double mutants were tested, including crd1Δanp1Δ, crd1Δptc7Δ,
crd1Δosm1Δ and crd1Δdog2Δ. All were rescued by 1 M sorbitol at elevated
temperature (Fig.4.2). This indicates that the corresponding genes are not required for
sorbitol rescue. 53 double mutants remain to be tested. The screen for double mutants
that cannot grow on YPD or YPD supplemented with 1 M sorbitol at elevated
temperature is an interesting direction to pursue in future studies.

4.

What is the mechanism underlying the vacuole defects in crd1Δ ?
A previous study in our lab found that, at elevated temperature, CL mutants

exhibit enlarged vacuoles and loss of vacuole acidification (Chen et al., 2008b). The
observed decrease in V-ATPase activity and proton pumping in crd1Δ may explain the
loss of acidification of the vacuole. However, the mechanism underlying the enlarged
vacuole morphology remains unknown. The following studies aimed to address the
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Table 4.1. Deletion strains used in the mini SGA

Standard name

Standard name

Standard name

YHR078W

SSK2

POR1

HKR1

VAC7

YPR1

NBP2

PTC2

PTC7

GRE1

PBS2

HSP12

PTC1

GRE2

PPZ2

IZH2

SSK1

PPZ1

OSM1

NHX1

YML131W

ANP1

FIG4

PTC3

MSN1

GON7

ZNF1

GLO1

GRE3

DOG2

RVS161

GPD1

MSB2

SKN7

YNL190W

POR2

STE50

PAI3

HOT1

SHO1

AGP2

AQY2

MPC3

PTP3

RVS167

PCK2

PTP2

STE11

SIP18

HIR1

YAR1

SMP1

RRD2

STL1

SKO1

YJL144W

GPP1
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crd1Δ

crd1Δosm1Δ crd1Δanp1Δ

crd1Δptc7Δ

crd1Δdog2Δ

YPDS

YPD

Fig. 4.2 Deletion of ANP1, PTC7, OSM1 or DOG2 does not
abrogate the rescue of crd1Δ temperature sensitivity by
sorbitol. Cells were pre-cultured in liquid YPD at 30˚C to the
mid-log phase. Approximately 200 cells of each strain were
plated on YPD or YPDS plates and incubated at 39.5°C for 3
days.
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potential mechanism of vacuole morphology defects in crd1Δ.

4.1 Increased nonselective autophagy may not be the cause of vacuole
enlargement
As described in Chapter 2, elevated temperature triggers increased expression
of the general autophagy gene, ATG8, in both crd1Δ and WT (Fig. 2.6). In addition, at
39°C, ATG8 expression is two-fold greater in crd1Δ than in WT. Although mitophagy is
defective in crd1Δ, nonselective autophagy may not be affected, as discussed in
Chapter 2. Because autophagy is the source of a large influx of lipid membrane and
cellular contents to the vacuole (Baba M et al., 1994; Baba et al., 1995; Takeshige K
et al., 1992), it is reasonable to speculate that increased nonselective autophagy may
be the cause of vacuole enlargement in crd1Δ.
If enlargement of the vacuole in crd1Δ at elevated temperature is due to
increased nonselective autophagy, deletion of the nonselective autophagy genes
should rescue the vacuole morphology defect of crd1Δ. To address this possibility, the
effect of deleting nonselective autophagy genes on vacuole morphology of crd1Δ cells
was determined. As seen in Fig. 4.3, crd1Δatg8Δ exhibited enlarged vacuoles similar
to crd1Δ, indicating that blocking nonselective autophagy does not rescue the vacuole
enlargement triggered by elevated temperature in crd1Δ.
In addition, if increased nonselective autophagy causes vacuole enlargement,
triggering nonselective autophagy should lead to enlarged vacuoles in WT and crd1Δ
at optimal temperature. To address this hypothesis, rapamycin, a stimulant of
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WT

crd1Δ

atg8Δ

crd1Δatg8Δ

FM4-64

DIC

Fig. 4.3 Deletion of ATG8 does not rescue the vacuole
enlargement triggered by elevated temperature in crd1Δ.
Cells were pre-cultured at 30 ℃ to the early log phase and
then transferred to 37℃ at a starting A550 of 0.5 for 8h. FM464 staining was performed and cells were observed using
fluorescence microscopy for vacuole morphology.
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nonselective autophagy, was used to trigger nonselective autophagy in WT and crd1Δ
at 30°C. FM 4-64 staining was performed to observe vacuole morphology. As seen in
Fig. 4.4, both crd1Δ and WT exhibited enlarged vacuoles, raising the possibility that
nonselective autophagy triggered by rapamycin results in enlarged vacuoles in even
WT. However, rapamycin has downstream effects other than autophagy. If the vacuole
enlargement triggered by rapamycin in crd1Δ and WT was due to increased
nonselective autophagy, but not to other downstream effects of rapamycin, deletion of
the nonselective autophagy genes in these strains should rescue vacuole morphology.
However, with rapamycin, atg8Δ and crd1Δatg8Δ exhibited enlarged vacuoles similar
to that in crd1Δ and WT, indicating that blocking autophagy does not rescue vacuole
enlargement triggered by rapamycin. Thus, the vacuole enlargement induced by
rapamycin is probably not due to increased nonselective autophagy. In addition to
triggering nonselective autophagy via the TOR1 pathway (Li et al., 2012; Yorimitsu et
al., 2007), rapamycin may be involved in other cellular processes that regulate vacuole
size.

4.2 Is the vacuole defect caused by perturbation of the FAB pathway in crd1Δ ?
The FAB pathway regulates the synthesis of phosphatidylinositol 3-phosphate
(PI3P) and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), which affects the size
and acidification of the vacuole. Interestingly, the fab1Δ mutant, in which PI(3,5)P2 is
undetectable, displays growth and vacuole defects that are similar to those in crd1Δ,
including decreased growth at elevated temperature, vacuole enlargement and loss of
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WT

crd1Δ

atg8Δ

crd1Δatg8Δ

FM4-64

DIC

Fig. 4.4 Rapamycin triggers enlargement of vacuoles in both WT
and crd1Δ, which is not rescued by deletion of ATG8. Cells were
pre-cultured at 30 ℃ to the early log phase and then transferred to
medium containing 10nM rapamycin at a starting A550 of 0.5 for 8h.
FM4-64 staining was performed and cells were observed using
fluorescence microscopy for vacuole morphology.
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vacuole acidification (Bonangelino et al., 2002; Gary et al., 1998; Yamamoto et al.,
1995). Thus, Chen et al. suggested that perturbation of the FAB pathway in CL
deficient cells may explain the vacuole defects. Chen determined that mRNA levels of
the FAB pathway genes were not affected in crd1Δ cells (Chen et al., 2008b). However,
FAB1 is not transcriptionally regulated (Gary et al., 1998). Therefore, nontranscriptional regulation of the FAB pathway may be defective in crd1Δ. Further
studies are necessary to address this possibility.

4.2.1 The FAB pathway
As shown in Fig. 4.5, the first step of the FAB pathway is the synthesis of PI3P
from PI, catalyzed by phosphatidylinositol (PI) 3-kinase, Vps34p (Auger et al., 1989;
Slessareva et al., 2006). Fab1p, which localizes to the vacuole membrane, catalyzes
the second step, converting vacuolar PI3P to PI(3,5)P2 (Dove et al., 2002; Gary et al.,
1998; Yamamoto et al., 1995). The reverse reaction to dephosphorylate PI(3,5)P2 to
PI3P is catalyzed by PI(3,5)P2 phosphatase, Fig4p (Rudge et al., 2004), which is also
needed for maximum function of Fab1p (Duex et al., 2006). Fab1p can be activated by
Vac7p and Vac14p (Bonangelino et al., 1997; Duex et al., 2006; Gary et al., 2002), the
latter of which is physically associated with Fig4p (Duex et al., 2006). Atg18p
negatively regulates Vac7p (Efe et al., 2005). This regulatory pathway controls levels
of PI(3,5)P2, which affect vacuole size and acidification. It is known that hyperosmotic
stress leads to increased PI(3,5)P2, resulting in shrunken and fragmented vacuoles
(Bonangelino et al., 2002; Dove et al., 1997), while loss of PI(3,5)P2 by deletion of
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Fig. 4.5 The FAB pathway and its regulation. Revised from
Efe et al., 2005.
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FAB1 leads to enlarged vacuoles (Gary et al., 1998; Odorizzi et al., 1998).

4.2.2 Is the FAB pathway perturbed in crd1Δ ?
To determine if there is perturbation of the FAB pathway in crd1Δ, I assessed
genetic interaction between crd1Δ and fig4Δ, because Fig4p is essential for both
synthesis and turn over of PI(3,5)P2. If the FAB pathway in crd1Δ is perturbed, no
matter whether there is altered synthesis of PI(3,5)P2, or altered turn-over of PI(3,5)P2,
I should see genetic interaction between FIG4 and CRD1. The ability of single cells to
form colonies was observed, using our lab generated crd1Δfig4Δ, fig4Δ, crd1Δ and WT
strains in the FGY background. As shown in Fig. 4.6, deletion of FIG4 partially rescued
the crd1Δ growth defect at 37.5°C, suggesting that the FAB pathway may be perturbed
in crd1Δ. Levels of PI(3,5)P2 may be decreased, and deletion of FIG4 may rescue the
growth defects of crd1Δ by blocking the dephosphorylation of PI(3,5)P2.

4.2.3

PI3P and PI(3,5)P2 are localized normally on the vacuole membrane of crd1Δ.
The findings described in section 4.2.2 provided a clue that the growth and

vacuole defects in crd1Δ may be due to perturbation of the FAB pathway. Thus, it was
necessary to determine if PI3P and PI(3,5)P2 on the vacuole membrane of crd1Δ are
decreased.
To directly observe if there is loss of PI3P or PI(3,5)P2 on the vacuole membrane,
both crd1Δ and WT cells were transformed with the pRS415-GFP-FYVE and pRS415GFP-ATG18 plasmids (kindly provided by Rania Deranieh), while fab1Δ containing the
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WT

fig4Δ

crd1Δ

crd1Δfig4Δ

Fig. 4.6 Deletion of FIG4 partially rescues crd1Δ
temperature sensitivity. Cells were pre-cultured in liquid
YPD at 30˚C to the mid-log phase. Approximately 200 cells of
each strain were plated on YPD plates and incubated at
37.5°C for 3 days.
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pRS415-GFP-ATG18 plasmid (kindly provided by Rania Deranieh) was used as a
negative control. The pRS415-GFP-FYVE plasmid expresses a protein in which GFP
is fused to the FYVE zinc finger domain. Binding of the FYVE domain of this probe to
PI3P enables the monitoring of PI3P intracellular localization. The pRS415-GFPATG18 plasmid expresses a PI(3,5)P2 specific fluorescent lipid-associated reporter
(FLARE), on which GFP is fused to the PI(3,5)P2 binding domain of Atg18p. At elevated
temperature, PI3P and PI(3,5)P2 vacuolar localization in crd1Δ was similar to that of
WT (Fig 4.7). In contrast, there is a loss of PI(3,5)P2 on the vacuole membrane in fab1Δ
(Fig 4.8), suggesting that loss of vacuolar PI(3,5)P2 may be the cause of the vacuole
defects in fab1Δ but not crd1Δ. However, normal PI3P and PI(3,5)P2 vacuole
localization does not exclude the possibility that PI(3,5)P2 levels are slightly decreased
in crd1Δ, which would not be discernible by comparison of fluorescence intensity.
Analysis of PI3P and PI(3,5)P2 levels by HPLC would be required to conclusively show
altered FAB pathway function.

4.2.4

Are protein levels of the FAB pathway regulators altered in crd1Δ ?
Although overexpression of FAB1 did not increase PI(3,5)P2 levels (Gary et al.,

1998), overexpression of FAB1 suppressed the vacuole defects in vac14Δ (Dove et
al., 2002). This finding suggests that, other than regulating synthesis of PI(3,5)P2,
Fab1p also directly controls vacuole size and acidification by a mechanism still unkown.
Thus, the protein levels of the FAB pathway regulators are also important for vacuole
morphology and acidification. Although Chen showed that the mRNA levels of FAB1,
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WT

crd1Δ

GFP

Phase Contrast

Fig. 4.7 crd1Δ exhibits normal PI3P localization at the vacuolar
membrane. Cells were pre-cultured at 30 ℃ to the early log
phase and then transferred to 37℃ at a starting A550 of 0.5 for 8h.
PI3P localization was then observed using fluorescence
microscopy.
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WT

GFP

crd1Δ

fab1Δ

GFP

Phase Contrast

Fig. 4.8 Normal vacuolar localization of PI(3,5)P2 in crd1Δ.
Cells were pre-cultured at 30℃ to the early log phase and then
transferred to 37℃ at a starting A550 of 0.5 for 8h. Cells were
then observed using fluorescence microscopy to determine
PI(3,5)P2 localization.
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VAC7, VAC14, VPS15, VPS34, FIG4, and ATG18 were not affected in crd1Δ cells, the
protein levels were not examined (Chen et al., 2008b).
The optimal way to address this question is to detect the protein levels of these
regulators by Western blot. However, primary antibodies against these proteins are not
commercially available. Thus, I employed an indirect approach to address this question.
If overexpression of FAB1 or VAC7 suppresses the vacuole defects in crd1Δ, it
suggests that Fab1p or Vac7p protein levels may be decreased in the mutant, which
may account for the vacuole defects. crd1Δ in the BY4742 background was
transformed with vectors expressing either FAB1 or VAC7

(or empty pYPGK18

vector as a negative control), plated on leu- plates, and incubated at 30⁰C or 38⁰C. The
ability of single cells to form colonies was observed. Overexpression of FAB1 and
VAC7 in crd1Δ did not rescue the growth defects of crd1Δ (Fig 4.9), indicating that
Fab1p and Vac7p protein levels may be unaltered in crd1Δ. However, it is possible
that there is targeted degradation of the FAB1 and VAC7 mRNA in crd1Δ, resulting in
not only degradation of endogenous FAB1 and VAC7 mRNA, but also FAB1 and VAC7
mRNA that is expressed from the overexpression vector.
To definitively ascertain if protein levels of FAB pathway regulators are altered in
CL deficient cells, Western blot detections of these proteins are required. Because the
primary antibodies against these proteins are not commercially available, an
alternative approach is to tag each FAB pathway regulator with the hemagglutinin (HA)
tag to enable the detection of these proteins by Western blot.
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30℃

38℃

crd1Δ-vec

crd1Δ-FAB1

crd1Δ-VAC7

Fig. 4.9 Overexpression of FAB1 and VAC7 does not rescue crd1Δ
temperature sensitivity. Cells were pre-cultured in liquid SC leu- at
30˚C to the mid-log phase. Approximately 200 cells of each strain were
plated on SC leu- plates and incubated at 38°C for 3 days.
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4.3 Are the vacuole defects in crd1Δ caused by perturbation of the Ena1 Na+ATPase exporter?

Vacuole size and acidification are regulated by PI(3,5)P2, as well as ion pumps
and channels presented in the vacuole membrane. These include the H+-Ca2+
exchanger Vcx1p, the Ca2+ pump Pmc1p, the Ca2+ channel Yvc1p, the H+-Na+
exchanger Nhx1p, and the voltage-sensitive Cl– channel Gef1p (Bonilla and
Cunningham, 2002; Ke et al., 2013; Li and Kane, 2009). Deletion of NHX1, but not the
genes encoding the other pumps or channels, suppresses vacuole defects and
temperature sensitivity of crd1Δ (Chen et al., 2008b). There is defective vacuolar VATPase activity and reduced proton transport in crd1Δ, causing decreased intravacuolar H+ levels (Chen et al., 2008b). Deletion of NHX1 blocks the vacuolar efflux of
H+ and influx of Na+, which may counteract the decreased vacuolar H+ level. However,
the mechanism whereby deletion of NHX1 rescues the vacuole morphology remains
to be elucidated.
Because deletion of NHX1 blocks the influx of Na+ into the vacuole, it is
reasonable to speculate that there may be excessive Na+ in the vacuole of crd1Δ. Na+
is sequestered in the vacuole when intracellular Na+ levels are increased (Li et al.,
2012). If there is excessive intra-vacuolar Na+ in crd1Δ, it may indicate increased
intracellular Na+ in this strain.
The amount of intracellular Na+ in Saccharomyces cerevisiae is tightly regulated
by activity of the ion pumps and channels on the cell membrane. The cell membrane
influx of Na+ is mainly induced by the Na+-K+ transporter Trk system and the non-
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specific cation channel Nsc1. Conversely, the efflux of Na+ is induced by the Na+/K+ATPase Ena1p and the Na+, K+/H+ antiporter Nha1p (Ke et al., 2013). Although Ena1p
and Nha1p are both involved in cell Na+ efflux, Nha1p plays a larger role in K+ extrusion
and cell survival under acidic conditions, while Ena1p is more involved in Na+ extrusion
and cell survival under alkaline conditions (Jung et al., 2012). In WT cells, heat shock
stimulates activity of the Na+-K+ pump (the Trk system) without affecting intracellular
Na+ levels (Boonstra et al., 1984), suggesting that the efflux of Na+ may be upregulated
to counteract stimulation of the Na+-K+ pump at elevated temperature. Thus, Na+ efflux
is essential for cell survival under heat stress.

4.3.1

Deletion of ENA1 does not exacerbate crd1Δ temperature sensitivity
I hypothesized that Na+ efflux is defective in crd1Δ at 39˚C, resulting in increased

intracellular Na+. To alleviate toxicity caused by increased intracellular Na+, vacuolar
Na+ influx is increased, resulting in increased osmotic pressure and vacuole
enlargement. To test my hypothesis, I investigated if there is genetic interaction
between CRD1 and ENA1, which encodes the major Na+ efflux transporter. Synthetic
lethality would suggest that Ena1p is defective in crd1Δ. A crd1Δena1Δ double mutant
was constructed by tetrad dissection and examined for temperature sensitivity.
Deletion of ENA1 did not exacerbate crd1Δ temperature sensitivity (Fig. 4.10),
suggesting that Ena1p may not be defective in crd1Δ.

4.3.2

Upregulation of ENA1 expression may be partially impaired in crd1Δ
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30˚C
WT
crd1Δ
ena1Δ
crd1Δena1Δ

39˚C
WT
crd1Δ
ena1Δ
crd1Δena1Δ
Fig. 4.10 Deletion of ENA1 does not affect crd1Δ
temperature sensitivity. Cells were pre-cultured in
liquid YPD at 30˚C to the mid-log phase. Aliquots were
adjusted to 2x108 cells/ml and then diluted in a 10X
serial dilution. Cells were spotted on YPD plates with
the most diluted spot containing 2000 cells, and the
plates were incubated at 30˚C or 39˚C for 2 days.
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Ena1p is regulated at the transcriptional level (Ke et al., 2013; Márquez JA and
R., 1996; Platara et al., 2006). To determine if there is defective Na+ efflux in crd1Δ at
39˚C, it is necessary to determine if ENA1 gene expression is decreased in crd1Δ
compared to WT at 39˚C. This would suggest that Na+ efflux will be decreased, leading
to increased intracellular Na+. WT and crd1Δ cells were incubated at either 30˚C or
39˚C for 2 hours. ENA1 expression in these strains was determined by RT-PCR. At
39˚C, ENA1 expression was upregulated in both WT and crd1Δ.

However,

upregulation of ENA1 expression in crd1Δ was less than in WT (Fig. 4.11), suggesting
that upregulation of ENA1 expression may be partially impaired in crd1Δ at elevated
temperature. Impaired ENA1 upregulation may lead to inadequate Na+ efflux and
accumulation of intracellular Na+, leading to vacuole enlargement.

4.3.3

Overexpression of ENA1 does not rescue crd1Δ temperature sensitivity
As seen in Fig.4.11, there may be impaired upregulation of ENA1 in crd1Δ at

39˚C. I then determined if overexpression of ENA1 rescues crd1Δ. crd1Δ was
transformed with a vector (pYPGK18) overexpressing ENA1, spotted on the leu- plates
and incubated at 30˚C or 39˚C. Overexpression of ENA1 did not affect crd1Δ
temperature sensitivity (Fig. 4.12), indicating that the growth and vacuole defects in
crd1Δ at elevated temperature are probably not due to impaired upregulation of ENA1
in crd1Δ.
The findings in Section 4.3.2 and 4.3.3 are controversial. To conclusively address
if there is increased intracellular Na+, the total Na+ level in crd1Δ at 39˚C should be
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WT 30˚C

crd1Δ 30˚C

WT 39˚C

crd1Δ 39˚C

Fig. 4.11 Inadequate ENA1 upregulation in crd1Δ
compared to WT, at elevated temperature. WT and
crd1Δ cells were cultured in YPD medium to the mid-log
phase at 30˚C and then incubated at either 30˚C or 39˚C
for 2 hours. ENA1 expression was determined by RT-PCR.
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30˚C
crd1Δ +

vec
ENA1

39˚C
crd1Δ +

vec
ENA1

Fig. 4.12 Overexpression of ENA1 does not rescue
crd1Δ temperature sensitivity. Cells were precultured in liquid SC leu- at 30˚C to the mid-log phase.
Aliquots were adjusted to 2x108 cells/ml and then
diluted in a 10X serial dilution. Cells were spotted on
YPD plates with the most diluted spot containing 2000
cells, and the plates were incubated at 30˚C or 39˚C
for 2 days.
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directly measured by isotachophoresis (Nakamura et al., 1993), an analytical
chemistry technique used for quantification of ionic analytes.

5.

Summary
In this chapter, I suggest future experiments to elucidate how CL regulates

mitophagy and MAPK pathways. In addition, experiments to investigate the role of CL
in vacuole homeostasis were described, and future directions related to this work have
been proposed. Much about CL remains to be elucidated. I encourage my junior
labmates to continue to explore the mystery of how CL contributes to human life and
health.
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Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, is
important for cardiovascular health. Perturbation of CL metabolism is implicated in
cardiovascular disease (CVD). The link between CL and CVD may be explained by the
physiological roles of CL in pathways that are cardioprotective, such as
autophagy/mitophagy and the mitogen-activated protein kinase (MAPK) pathways. My
dissertation work focuses on elucidating how CL influences mitophagy and MAPK
pathways.
crd1Δ was synthetically lethal/sick with the general autophagy mutants atg8Δ,
atg18Δ and mitophagy mutant atg32Δ, suggesting that autophagy/mitophagy may be
deficient in cells lacking CL. Microscopic examination of mitophagy revealed
decreased translocation of GFP-tagged mitochondrial proteins into the vacuole of
crd1Δ cells. This was confirmed by a decreased level of free GFP generated by
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cleavage of GFP-tagged mitochondrial protein after delivery into the vacuole by
mitophagy. These findings indicated that mitophagy is decreased in CL-deficient cells.
Expression of ATG8 was increased in crd1Δ cells at 37˚C, suggesting that nonselective
autophagy was upregulated to compensate for decreased mitophagy.
The PKC and HOG MAPK pathways are known to be required for mitophagy.
crd1Δ growth defects are exacerbated by deletion of HOG pathway genes SHO1,
SSK1, STE50 and HOG1, and rescued by stimulating the HOG pathway and
upregulating the PKC pathway. These findings suggested the possibility that MAPK
pathways are defective in crd1Δ cells. Phosphorylation of Slt2p and Hog1p in response
to stimulants was decreased in crd1Δ, consistent with defective activation of these
MAPK pathways. Interestingly, upregulating PKC by transforming the cell with a vector
expressing a constitutively activated Pkc1p rescued defective mitophagy in crd1Δ.
These results suggest that the mechanism underlying defective mitophagy
caused by loss of CL is a defective PKC pathway.
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